activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147200	CHEMBL927944	Activity of human BrSK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	99.0	CHEMBL4574	Homo sapiens	Activity	%	99.0
	2147200	CHEMBL927944	Activity of human BrSK2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	99.0	CHEMBL4574	Homo sapiens	Activity	%	99.0
Not Active	2302210	CHEMBL945703	Inhibition of human BRSK2 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL4574	Homo sapiens	INH		
	2470124	CHEMBL1032267	Inhibition of BRSK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4574	Homo sapiens	INH	%	10.0
Not Evaluated	2476723	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4574	Homo sapiens	Activity		
	2477876	CHEMBL988909	Binding affinity to human BRSK2	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Kd	nM	92.0	CHEMBL4574	Homo sapiens	Kd	nM	92.0
Not Evaluated	2478562	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4574	Homo sapiens	Activity		
	2478765	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	32.75	CHEMBL4574	Homo sapiens	Activity	%	32.75
Not Evaluated	2479620	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4574	Homo sapiens	Activity		
	2479823	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	30.3	CHEMBL4574	Homo sapiens	Activity	%	30.3
Active	2480620	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4574	Homo sapiens	Activity		
	2480822	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	8.7	CHEMBL4574	Homo sapiens	Activity	%	8.7
Not Evaluated	2577241	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4574	Homo sapiens	Activity		
Not Evaluated	2577444	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4574	Homo sapiens	Activity		
Not Evaluated	2593649	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4574	Homo sapiens	Activity		
	2593915	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.1	CHEMBL4574	Homo sapiens	Activity	%	0.1
Not Evaluated	2594118	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4574	Homo sapiens	Activity		
Not Evaluated	2594858	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4574	Homo sapiens	Activity		
Not Evaluated	2595061	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4574	Homo sapiens	Activity		
Not Evaluated	2596258	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4574	Homo sapiens	Activity		
	2596461	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	6.55	CHEMBL4574	Homo sapiens	Activity	%	6.55
Not Evaluated	2597730	CHEMBL982751	Binding affinity to human BRSK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4574	Homo sapiens	Activity		
	2635926	CHEMBL1004138	Inhibition of BRSK2 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	50.0	CHEMBL4574	Homo sapiens	Residual_activity	%	50.0
	2635994	CHEMBL1004138	Inhibition of BRSK2 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	50.0	CHEMBL4574	Homo sapiens	Residual_activity	%	50.0
	2636062	CHEMBL1004138	Inhibition of BRSK2 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL4574	Homo sapiens	Residual_activity	%	75.0
	2721559	CHEMBL1060967	Inhibition of BrSK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
Antagonist	2897270	CHEMBL1061990	Inhibition of BRSK2 in the presence of 50uM ATP	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1100.0	CHEMBL4574	Homo sapiens	IC50	uM	1.1
Antagonist	2897271	CHEMBL1061990	Inhibition of BRSK2 in the presence of 50uM ATP	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	100.0	CHEMBL4574	Homo sapiens	IC50	uM	0.1
	2898431	CHEMBL1062893	Percentage BRSK2 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	92.0	CHEMBL4574	Homo sapiens	Activity	%	92.0
	2898432	CHEMBL1062893	Percentage BRSK2 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	88.0	CHEMBL4574	Homo sapiens	Activity	%	88.0
Antagonist	2898433	CHEMBL1062893	Percentage BRSK2 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	27.0	CHEMBL4574	Homo sapiens	Activity	%	27.0
	2898434	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	78.0	CHEMBL4574	Homo sapiens	Activity	%	78.0
Antagonist	2898435	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	45.0	CHEMBL4574	Homo sapiens	Activity	%	45.0
	2898436	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	79.0	CHEMBL4574	Homo sapiens	Activity	%	79.0
	2898437	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	76.0	CHEMBL4574	Homo sapiens	Activity	%	76.0
	2898438	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	65.0	CHEMBL4574	Homo sapiens	Activity	%	65.0
Antagonist	2898439	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	46.0	CHEMBL4574	Homo sapiens	Activity	%	46.0
	2898440	CHEMBL1061994	Percentage BRSK2 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	67.0	CHEMBL4574	Homo sapiens	Activity	%	67.0
	2898441	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	82.0	CHEMBL4574	Homo sapiens	Activity	%	82.0
	2898442	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	2898443	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	76.0	CHEMBL4574	Homo sapiens	Activity	%	76.0
Antagonist	2898444	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	23.0	CHEMBL4574	Homo sapiens	Activity	%	23.0
	2898445	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	90.0	CHEMBL4574	Homo sapiens	Activity	%	90.0
	2898446	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	84.0	CHEMBL4574	Homo sapiens	Activity	%	84.0
	2898447	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	104.0	CHEMBL4574	Homo sapiens	Activity	%	104.0
	2898448	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	73.0	CHEMBL4574	Homo sapiens	Activity	%	73.0
	2898449	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	92.0	CHEMBL4574	Homo sapiens	Activity	%	92.0
	2898450	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	64.0	CHEMBL4574	Homo sapiens	Activity	%	64.0
Antagonist	2898451	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	38.0	CHEMBL4574	Homo sapiens	Activity	%	38.0
Antagonist	2898452	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	42.0	CHEMBL4574	Homo sapiens	Activity	%	42.0
Antagonist	2898453	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	45.0	CHEMBL4574	Homo sapiens	Activity	%	45.0
	2898454	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	57.0	CHEMBL4574	Homo sapiens	Activity	%	57.0
	2898455	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	77.0	CHEMBL4574	Homo sapiens	Activity	%	77.0
	2898456	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	2898457	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	2898458	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	78.0	CHEMBL4574	Homo sapiens	Activity	%	78.0
	2898459	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	80.0	CHEMBL4574	Homo sapiens	Activity	%	80.0
	2898460	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	80.0	CHEMBL4574	Homo sapiens	Activity	%	80.0
	2898461	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	90.0	CHEMBL4574	Homo sapiens	Activity	%	90.0
	2898462	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	87.0	CHEMBL4574	Homo sapiens	Activity	%	87.0
	2898463	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	87.0	CHEMBL4574	Homo sapiens	Activity	%	87.0
	2898464	CHEMBL1051366	Percentage BRSK2 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	93.0	CHEMBL4574	Homo sapiens	Activity	%	93.0
Antagonist	2898465	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	47.0	CHEMBL4574	Homo sapiens	Activity	%	47.0
	2898466	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	67.0	CHEMBL4574	Homo sapiens	Activity	%	67.0
	2898467	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	2898468	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	72.0	CHEMBL4574	Homo sapiens	Activity	%	72.0
	2898469	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	62.0	CHEMBL4574	Homo sapiens	Activity	%	62.0
	2898470	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	53.0	CHEMBL4574	Homo sapiens	Activity	%	53.0
Antagonist	2898471	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	39.0	CHEMBL4574	Homo sapiens	Activity	%	39.0
	2898472	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	86.0	CHEMBL4574	Homo sapiens	Activity	%	86.0
	2898473	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	71.0	CHEMBL4574	Homo sapiens	Activity	%	71.0
	2898474	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	80.0	CHEMBL4574	Homo sapiens	Activity	%	80.0
	2898475	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	79.0	CHEMBL4574	Homo sapiens	Activity	%	79.0
Antagonist	2898476	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	37.0	CHEMBL4574	Homo sapiens	Activity	%	37.0
Antagonist	2898477	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	41.0	CHEMBL4574	Homo sapiens	Activity	%	41.0
	2898478	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	93.0	CHEMBL4574	Homo sapiens	Activity	%	93.0
Antagonist	2898479	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	44.0	CHEMBL4574	Homo sapiens	Activity	%	44.0
	2898480	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	92.0	CHEMBL4574	Homo sapiens	Activity	%	92.0
	2898481	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	83.0	CHEMBL4574	Homo sapiens	Activity	%	83.0
	2898482	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	98.0	CHEMBL4574	Homo sapiens	Activity	%	98.0
	2898483	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	101.0	CHEMBL4574	Homo sapiens	Activity	%	101.0
	2898484	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	103.0	CHEMBL4574	Homo sapiens	Activity	%	103.0
	2898485	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	93.0	CHEMBL4574	Homo sapiens	Activity	%	93.0
	2898486	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	82.0	CHEMBL4574	Homo sapiens	Activity	%	82.0
Antagonist	2898487	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	42.0	CHEMBL4574	Homo sapiens	Activity	%	42.0
Antagonist	2898488	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	46.0	CHEMBL4574	Homo sapiens	Activity	%	46.0
	2898489	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	108.0	CHEMBL4574	Homo sapiens	Activity	%	108.0
	2898490	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	86.0	CHEMBL4574	Homo sapiens	Activity	%	86.0
	2898491	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	101.0	CHEMBL4574	Homo sapiens	Activity	%	101.0
	2898492	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	90.0	CHEMBL4574	Homo sapiens	Activity	%	90.0
Antagonist	2898493	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	10.0	CHEMBL4574	Homo sapiens	Activity	%	10.0
Antagonist	2898494	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	15.0	CHEMBL4574	Homo sapiens	Activity	%	15.0
	2898495	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	92.0	CHEMBL4574	Homo sapiens	Activity	%	92.0
	2898496	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	96.0	CHEMBL4574	Homo sapiens	Activity	%	96.0
	2898497	CHEMBL1051367	Percentage BRSK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	90.0	CHEMBL4574	Homo sapiens	Activity	%	90.0
	2898498	CHEMBL1061919	Percentage BRSK2 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	88.0	CHEMBL4574	Homo sapiens	Activity	%	88.0
Antagonist	2898499	CHEMBL1061919	Percentage BRSK2 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	42.0	CHEMBL4574	Homo sapiens	Activity	%	42.0
	2898500	CHEMBL1051368	Percentage BRSK2 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	83.0	CHEMBL4574	Homo sapiens	Activity	%	83.0
	2898501	CHEMBL1052068	Percentage BRSK2 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	53.0	CHEMBL4574	Homo sapiens	Activity	%	53.0
	2903581	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903582	CHEMBL1061136	Binding constant for full-length BRSK2	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903583	CHEMBL1061136	Binding constant for full-length BRSK2	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903584	CHEMBL1061136	Binding constant for full-length BRSK2	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903585	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903586	CHEMBL1061136	Binding constant for full-length BRSK2	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903587	CHEMBL1061136	Binding constant for full-length BRSK2	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903588	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903589	CHEMBL1061136	Binding constant for full-length BRSK2	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903590	CHEMBL1061136	Binding constant for full-length BRSK2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903591	CHEMBL1061136	Binding constant for full-length BRSK2	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903592	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903593	CHEMBL1061136	Binding constant for full-length BRSK2	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903594	CHEMBL1061136	Binding constant for full-length BRSK2	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903595	CHEMBL1061136	Binding constant for full-length BRSK2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903596	CHEMBL1061136	Binding constant for full-length BRSK2	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903597	CHEMBL1061136	Binding constant for full-length BRSK2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903598	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903599	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903600	CHEMBL1061136	Binding constant for full-length BRSK2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	2700.0	CHEMBL4574	Homo sapiens	Kd	nM	2700.0
	2903601	CHEMBL1061136	Binding constant for full-length BRSK2	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903602	CHEMBL1061136	Binding constant for full-length BRSK2	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903603	CHEMBL1061136	Binding constant for full-length BRSK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903604	CHEMBL1061136	Binding constant for full-length BRSK2	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903605	CHEMBL1061136	Binding constant for full-length BRSK2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903606	CHEMBL1061136	Binding constant for full-length BRSK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	650.0	CHEMBL4574	Homo sapiens	Kd	nM	650.0
	2903607	CHEMBL1061136	Binding constant for full-length BRSK2	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903608	CHEMBL1061136	Binding constant for full-length BRSK2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903609	CHEMBL1061136	Binding constant for full-length BRSK2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903610	CHEMBL1061136	Binding constant for full-length BRSK2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903611	CHEMBL1061136	Binding constant for full-length BRSK2	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903612	CHEMBL1061136	Binding constant for full-length BRSK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903613	CHEMBL1061136	Binding constant for full-length BRSK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.5	CHEMBL4574	Homo sapiens	Kd	nM	3.5
	2903614	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4100.0	CHEMBL4574	Homo sapiens	Kd	nM	4100.0
	2903615	CHEMBL1061136	Binding constant for full-length BRSK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1100.0	CHEMBL4574	Homo sapiens	Kd	nM	1100.0
	2903616	CHEMBL1061136	Binding constant for full-length BRSK2	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903617	CHEMBL1061136	Binding constant for full-length BRSK2	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2903618	CHEMBL1061136	Binding constant for full-length BRSK2	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	2921423	CHEMBL1052869	Inhibition of BRSK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	87.0	CHEMBL4574	Homo sapiens	Activity	%	87.0
	2924837	CHEMBL1056882	Inhibition of BRSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	76.0	CHEMBL4574	Homo sapiens	Activity	%	76.0
	2924838	CHEMBL1056882	Inhibition of BRSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	58.0	CHEMBL4574	Homo sapiens	Activity	%	58.0
	2924839	CHEMBL1056882	Inhibition of BRSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	101.0	CHEMBL4574	Homo sapiens	Activity	%	101.0
	2924840	CHEMBL1056882	Inhibition of BRSK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	22.0	CHEMBL4574	Homo sapiens	Activity	%	22.0
	2926227	CHEMBL1054467	Inhibition of BRSK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	81.0	CHEMBL4574	Homo sapiens	Activity	%	81.0
	2928413	CHEMBL1055324	Inhibition of BRSK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	82.0	CHEMBL4574	Homo sapiens	Activity	%	82.0
	2938527	CHEMBL1041338	Inhibition of BRSK2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	2.0	CHEMBL4574	Homo sapiens	INH	%	2.0
	2999023	CHEMBL1043726	Inhibition of BRSK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	87.0	CHEMBL4574	Homo sapiens	Activity	%	87.0
	2999813	CHEMBL1043726	Inhibition of BRSK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	93.0	CHEMBL4574	Homo sapiens	Activity	%	93.0
	2999886	CHEMBL1049888	Inhibition of BRSK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	86.0	CHEMBL4574	Homo sapiens	Activity	%	86.0
	2999962	CHEMBL1049888	Inhibition of BRSK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	3213881	CHEMBL1114029	Inhibition of BRSK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	7.0	CHEMBL4574	Homo sapiens	INH	%	7.0
	3260094	CHEMBL1108074	Inhibition of BRSK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	36.0	CHEMBL4574	Homo sapiens	Activity	%	36.0
	3261379	CHEMBL1108074	Inhibition of BRSK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	29.0	CHEMBL4574	Homo sapiens	Activity	%	29.0
	3331846	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3333261	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3334666	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3336086	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3337467	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3337715	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3339047	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3340349	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	63.8	CHEMBL4574	Homo sapiens	INH	%	63.8
	3340614	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3342030	CHEMBL1168805	Inhibition of BRSK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	3358473	CHEMBL1174087	Inhibition of BRSK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	81.0	CHEMBL4574	Homo sapiens	INH	%	81.0
	3358915	CHEMBL1174087	Inhibition of BRSK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	90.0	CHEMBL4574	Homo sapiens	INH	%	90.0
	3445045	CHEMBL1244743	Binding affinity to BRSK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	16.0	CHEMBL4574	Homo sapiens	Kd	nM	16.0
	3448889	CHEMBL1244743	Binding affinity to BRSK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	650.0	CHEMBL4574	Homo sapiens	Kd	nM	650.0
	3449398	CHEMBL1244743	Binding affinity to BRSK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1100.0	CHEMBL4574	Homo sapiens	Kd	nM	1100.0
	3449579	CHEMBL1244743	Binding affinity to BRSK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	3450003	CHEMBL1244743	Binding affinity to BRSK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	3450927	CHEMBL1244743	Binding affinity to BRSK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	3451218	CHEMBL1244743	Binding affinity to BRSK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	uM	10.0
	5120346	CHEMBL1648183	Inhibition of human BrSK2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	103.0	CHEMBL4574	Homo sapiens	INH	%	103.0
	5133706	CHEMBL1648706	Inhibition of BRSK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	5133801	CHEMBL1648706	Inhibition of BRSK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	5133870	CHEMBL1648706	Inhibition of BRSK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	5191407	CHEMBL1664060	Inhibition of BRSK2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	25.0	CHEMBL4574	Homo sapiens	INH	%	25.0
	5191408	CHEMBL1664060	Inhibition of BRSK2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	24.0	CHEMBL4574	Homo sapiens	INH	%	24.0
	6169206	CHEMBL1768984	Inhibition of human BRSK2 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	44.0	CHEMBL4574	Homo sapiens	Activity	%	44.0
	6274421	CHEMBL1806161	Inhibition of BRSK2 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	108.0	CHEMBL4574	Homo sapiens	Activity	%	108.0
	6340980	CHEMBL1827566	Activity of BRSK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	6352192	CHEMBL1825647	Inhibition of BRSK2 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	62.0	CHEMBL4574	Homo sapiens	Activity	%	62.0
	7567327	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7567786	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7568283	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	8900.0	CHEMBL4574	Homo sapiens	Kd	nM	8900.0
	7568715	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4100.0	CHEMBL4574	Homo sapiens	Kd	nM	4100.0
	7569300	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7569760	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7569790	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7570253	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7570680	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1100.0	CHEMBL4574	Homo sapiens	Kd	nM	1100.0
	7571276	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7571767	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7572230	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7572646	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	190.0	CHEMBL4574	Homo sapiens	Kd	nM	190.0
	7573272	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7573748	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7574217	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	650.0	CHEMBL4574	Homo sapiens	Kd	nM	650.0
	7574625	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	1200.0	CHEMBL4574	Homo sapiens	Kd	nM	1200.0
	7574793	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7575254	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7575725	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7576190	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7576598	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7576767	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7577226	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7577704	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1200.0	CHEMBL4574	Homo sapiens	Kd	nM	1200.0
	7578174	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	42.0	CHEMBL4574	Homo sapiens	Kd	nM	42.0
	7578579	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7578775	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7579149	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7579599	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7580073	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7581133	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7581518	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7581963	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7582434	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7582456	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7582856	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7583479	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7583876	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	5600.0	CHEMBL4574	Homo sapiens	Kd	nM	5600.0
	7584321	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7584812	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7585216	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7585809	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7586217	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7586692	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7587146	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7587770	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7588200	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7588671	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7589122	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7589717	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	16.0	CHEMBL4574	Homo sapiens	Kd	nM	16.0
	7590184	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7590658	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7591109	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7591266	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7591688	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7592160	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	8300.0	CHEMBL4574	Homo sapiens	Kd	nM	8300.0
	7592633	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7593086	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7593233	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7593668	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7594140	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7594613	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7595065	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7595201	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7595645	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7596119	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7596590	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7597173	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7597626	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7598099	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
	7598569	CHEMBL1908626	Binding constant for BRSK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3.5	CHEMBL4574	Homo sapiens	Kd	nM	3.5
	7969697	CHEMBL1930953	Inhibition of BRSK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	73.0	CHEMBL4574	Homo sapiens	Activity	%	73.0
	7978807	CHEMBL1930060	Inhibition of human BRSK2 at 1 uM	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	84.0	CHEMBL4574	Homo sapiens	INH	%	84.0
	8061256	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.21	CHEMBL4574	Homo sapiens	Inhibition	%	-0.21
	8061433	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	2.95	CHEMBL4574	Homo sapiens	Inhibition	%	2.95
	8061764	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.93	CHEMBL4574	Homo sapiens	Inhibition	%	1.93
	8061955	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.03	CHEMBL4574	Homo sapiens	Inhibition	%	6.03
	8062179	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	12.35	CHEMBL4574	Homo sapiens	Inhibition	%	12.35
	8062295	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.19	CHEMBL4574	Homo sapiens	Inhibition	%	3.19
	8062681	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.08	CHEMBL4574	Homo sapiens	Inhibition	%	4.08
	8062779	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.91	CHEMBL4574	Homo sapiens	Inhibition	%	0.91
	8063003	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.4	CHEMBL4574	Homo sapiens	Inhibition	%	1.4
	8063135	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.33	CHEMBL4574	Homo sapiens	Inhibition	%	1.33
	8063302	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.7	CHEMBL4574	Homo sapiens	Inhibition	%	2.7
	8063526	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.49	CHEMBL4574	Homo sapiens	Inhibition	%	4.49
	8063634	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.53	CHEMBL4574	Homo sapiens	Inhibition	%	0.53
	8064040	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.37	CHEMBL4574	Homo sapiens	Inhibition	%	2.37
	8064155	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.4	CHEMBL4574	Homo sapiens	Inhibition	%	6.4
	8064379	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.26	CHEMBL4574	Homo sapiens	Inhibition	%	2.26
	8064589	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.44	CHEMBL4574	Homo sapiens	Inhibition	%	1.44
	8064727	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.9	CHEMBL4574	Homo sapiens	Inhibition	%	0.9
	8065117	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.16	CHEMBL4574	Homo sapiens	Inhibition	%	3.16
	8065233	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.06	CHEMBL4574	Homo sapiens	Inhibition	%	1.06
	8065457	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.0	CHEMBL4574	Homo sapiens	Inhibition	%	2.0
	8065632	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.54	CHEMBL4574	Homo sapiens	Inhibition	%	2.54
	8065971	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.76	CHEMBL4574	Homo sapiens	Inhibition	%	2.76
	8066181	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.16	CHEMBL4574	Homo sapiens	Inhibition	%	2.16
	8066317	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	12.79	CHEMBL4574	Homo sapiens	Inhibition	%	12.79
	8066541	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.3	CHEMBL4574	Homo sapiens	Inhibition	%	0.3
	8066707	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	10.65	CHEMBL4574	Homo sapiens	Inhibition	%	10.65
	8067055	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.84	CHEMBL4574	Homo sapiens	Inhibition	%	0.84
	8067230	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.33	CHEMBL4574	Homo sapiens	Inhibition	%	2.33
	8067575	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.69	CHEMBL4574	Homo sapiens	Inhibition	%	1.69
	8067785	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.53	CHEMBL4574	Homo sapiens	Inhibition	%	4.53
	8068144	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.76	CHEMBL4574	Homo sapiens	Inhibition	%	6.76
	8068308	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.65	CHEMBL4574	Homo sapiens	Inhibition	%	0.65
	8068657	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.78	CHEMBL4574	Homo sapiens	Inhibition	%	0.78
	8068831	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.89	CHEMBL4574	Homo sapiens	Inhibition	%	2.89
	8069055	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.67	CHEMBL4574	Homo sapiens	Inhibition	%	1.67
	8069180	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.78	CHEMBL4574	Homo sapiens	Inhibition	%	0.78
	8069475	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	3.01	CHEMBL4574	Homo sapiens	Inhibition	%	3.01
	8069636	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.0	CHEMBL4574	Homo sapiens	Inhibition	%	5.0
	8069860	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.16	CHEMBL4574	Homo sapiens	Inhibition	%	1.16
	8069986	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.38	CHEMBL4574	Homo sapiens	Inhibition	%	2.38
	8070382	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.66	CHEMBL4574	Homo sapiens	Inhibition	%	0.66
	8070507	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.14	CHEMBL4574	Homo sapiens	Inhibition	%	0.14
	8070805	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	8.68	CHEMBL4574	Homo sapiens	Inhibition	%	8.68
	8071186	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.77	CHEMBL4574	Homo sapiens	Inhibition	%	3.77
	8071312	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.17	CHEMBL4574	Homo sapiens	Inhibition	%	2.17
	8071536	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.14	CHEMBL4574	Homo sapiens	Inhibition	%	2.14
	8071709	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.32	CHEMBL4574	Homo sapiens	Inhibition	%	3.32
	8071834	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.33	CHEMBL4574	Homo sapiens	Inhibition	%	0.33
	8072058	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.27	CHEMBL4574	Homo sapiens	Inhibition	%	-0.27
	8072148	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.38	CHEMBL4574	Homo sapiens	Inhibition	%	1.38
	8072372	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.1	CHEMBL4574	Homo sapiens	Inhibition	%	2.1
	8072529	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.79	CHEMBL4574	Homo sapiens	Inhibition	%	0.79
	8072878	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.49	CHEMBL4574	Homo sapiens	Inhibition	%	0.49
	8073045	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	11.46	CHEMBL4574	Homo sapiens	Inhibition	%	11.46
	8073394	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.24	CHEMBL4574	Homo sapiens	Inhibition	%	0.24
	8073513	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.09	CHEMBL4574	Homo sapiens	Inhibition	%	3.09
	8073737	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	12.82	CHEMBL4574	Homo sapiens	Inhibition	%	12.82
	8073970	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.38	CHEMBL4574	Homo sapiens	Inhibition	%	1.38
	8074122	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.06	CHEMBL4574	Homo sapiens	Inhibition	%	2.06
	8074476	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	8.59	CHEMBL4574	Homo sapiens	Inhibition	%	8.59
	8074633	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.74	CHEMBL4574	Homo sapiens	Inhibition	%	4.74
	8074984	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.35	CHEMBL4574	Homo sapiens	Inhibition	%	-0.35
	8075319	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.32	CHEMBL4574	Homo sapiens	Inhibition	%	1.32
	8075556	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.23	CHEMBL4574	Homo sapiens	Inhibition	%	3.23
	8075697	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.73	CHEMBL4574	Homo sapiens	Inhibition	%	1.73
	8075921	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.47	CHEMBL4574	Homo sapiens	Inhibition	%	2.47
	8076063	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	6.06	CHEMBL4574	Homo sapiens	Inhibition	%	6.06
	8076211	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.25	CHEMBL4574	Homo sapiens	Inhibition	%	5.25
	8076435	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	58.34	CHEMBL4574	Homo sapiens	Inhibition	%	58.34
	8076569	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.59	CHEMBL4574	Homo sapiens	Inhibition	%	-0.59
	8076895	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.21	CHEMBL4574	Homo sapiens	Inhibition	%	-0.21
	8077142	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	13.71	CHEMBL4574	Homo sapiens	Inhibition	%	13.71
	8077494	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.39	CHEMBL4574	Homo sapiens	Inhibition	%	2.39
	8077645	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	36.45	CHEMBL4574	Homo sapiens	Inhibition	%	36.45
	8078012	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	80.33	CHEMBL4574	Homo sapiens	Inhibition	%	80.33
	8078151	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.75	CHEMBL4574	Homo sapiens	Inhibition	%	2.75
	8078375	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	16.68	CHEMBL4574	Homo sapiens	Inhibition	%	16.68
	8078477	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.35	CHEMBL4574	Homo sapiens	Inhibition	%	-0.35
	8078727	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	58.84	CHEMBL4574	Homo sapiens	Inhibition	%	58.84
	8079067	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.23	CHEMBL4574	Homo sapiens	Inhibition	%	4.23
	8079225	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	24.2	CHEMBL4574	Homo sapiens	Inhibition	%	24.2
	8079449	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	68.34	CHEMBL4574	Homo sapiens	Inhibition	%	68.34
	8079591	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.69	CHEMBL4574	Homo sapiens	Inhibition	%	4.69
	8079954	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.24	CHEMBL4574	Homo sapiens	Inhibition	%	2.24
	8080059	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.99	CHEMBL4574	Homo sapiens	Inhibition	%	1.99
	8080311	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	10.08	CHEMBL4574	Homo sapiens	Inhibition	%	10.08
	8080535	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	50.12	CHEMBL4574	Homo sapiens	Inhibition	%	50.12
	8080650	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.22	CHEMBL4574	Homo sapiens	Inhibition	%	2.22
	8081038	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.95	CHEMBL4574	Homo sapiens	Inhibition	%	1.95
	8081173	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.63	CHEMBL4574	Homo sapiens	Inhibition	%	5.63
	8081541	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.88	CHEMBL4574	Homo sapiens	Inhibition	%	6.88
	8081644	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.05	CHEMBL4574	Homo sapiens	Inhibition	%	2.05
	8081868	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	18.99	CHEMBL4574	Homo sapiens	Inhibition	%	18.99
	8082120	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.61	CHEMBL4574	Homo sapiens	Inhibition	%	0.61
	8082233	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.79	CHEMBL4574	Homo sapiens	Inhibition	%	1.79
	8082457	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.08	CHEMBL4574	Homo sapiens	Inhibition	%	1.08
	8082630	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	7.44	CHEMBL4574	Homo sapiens	Inhibition	%	7.44
	8082753	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.53	CHEMBL4574	Homo sapiens	Inhibition	%	1.53
	8082977	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.25	CHEMBL4574	Homo sapiens	Inhibition	%	4.25
	8083133	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	8.96	CHEMBL4574	Homo sapiens	Inhibition	%	8.96
	8083456	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.32	CHEMBL4574	Homo sapiens	Inhibition	%	2.32
	8083710	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	6.14	CHEMBL4574	Homo sapiens	Inhibition	%	6.14
	8084044	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.04	CHEMBL4574	Homo sapiens	Inhibition	%	7.04
	8084229	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	60.35	CHEMBL4574	Homo sapiens	Inhibition	%	60.35
	8084571	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.27	CHEMBL4574	Homo sapiens	Inhibition	%	2.27
	8084732	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	46.02	CHEMBL4574	Homo sapiens	Inhibition	%	46.02
	8085054	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	19.15	CHEMBL4574	Homo sapiens	Inhibition	%	19.15
	8085310	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.53	CHEMBL4574	Homo sapiens	Inhibition	%	0.53
	8085642	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.56	CHEMBL4574	Homo sapiens	Inhibition	%	0.56
	8085831	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	80.7	CHEMBL4574	Homo sapiens	Inhibition	%	80.7
	8086170	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	9.3	CHEMBL4574	Homo sapiens	Inhibition	%	9.3
	8086332	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.63	CHEMBL4574	Homo sapiens	Inhibition	%	6.63
	8086556	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	36.07	CHEMBL4574	Homo sapiens	Inhibition	%	36.07
	8086655	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.34	CHEMBL4574	Homo sapiens	Inhibition	%	1.34
	8086866	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.54	CHEMBL4574	Homo sapiens	Inhibition	%	1.54
	8087090	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	9.33	CHEMBL4574	Homo sapiens	Inhibition	%	9.33
	8087248	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.47	CHEMBL4574	Homo sapiens	Inhibition	%	1.47
	8087586	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.96	CHEMBL4574	Homo sapiens	Inhibition	%	2.96
	8087724	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.75	CHEMBL4574	Homo sapiens	Inhibition	%	4.75
	8087948	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.01	CHEMBL4574	Homo sapiens	Inhibition	%	0.01
	8088090	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.15	CHEMBL4574	Homo sapiens	Inhibition	%	2.15
	8088238	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.92	CHEMBL4574	Homo sapiens	Inhibition	%	0.92
	8088462	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.21	CHEMBL4574	Homo sapiens	Inhibition	%	2.21
	8088590	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	19.38	CHEMBL4574	Homo sapiens	Inhibition	%	19.38
	8088907	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	9.49	CHEMBL4574	Homo sapiens	Inhibition	%	9.49
	8089259	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.24	CHEMBL4574	Homo sapiens	Inhibition	%	0.24
	8089407	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	14.56	CHEMBL4574	Homo sapiens	Inhibition	%	14.56
	8089751	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.64	CHEMBL4574	Homo sapiens	Inhibition	%	0.64
	8089931	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.77	CHEMBL4574	Homo sapiens	Inhibition	%	-0.77
	8090320	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.2	CHEMBL4574	Homo sapiens	Inhibition	%	-0.2
	8090487	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.22	CHEMBL4574	Homo sapiens	Inhibition	%	1.22
	8090850	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.94	CHEMBL4574	Homo sapiens	Inhibition	%	1.94
	8091055	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.82	CHEMBL4574	Homo sapiens	Inhibition	%	2.82
	8091416	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.36	CHEMBL4574	Homo sapiens	Inhibition	%	2.36
	8091571	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.78	CHEMBL4574	Homo sapiens	Inhibition	%	2.78
	8091911	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.49	CHEMBL4574	Homo sapiens	Inhibition	%	4.49
	8092272	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.57	CHEMBL4574	Homo sapiens	Inhibition	%	2.57
	8092423	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.67	CHEMBL4574	Homo sapiens	Inhibition	%	0.67
	8092795	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.22	CHEMBL4574	Homo sapiens	Inhibition	%	0.22
	8092924	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	58.87	CHEMBL4574	Homo sapiens	Inhibition	%	58.87
	8093148	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.22	CHEMBL4574	Homo sapiens	Inhibition	%	6.22
	8093236	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.44	CHEMBL4574	Homo sapiens	Inhibition	%	1.44
	8093600	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.42	CHEMBL4574	Homo sapiens	Inhibition	%	0.42
	8093739	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	58.19	CHEMBL4574	Homo sapiens	Inhibition	%	58.19
	8093963	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.19	CHEMBL4574	Homo sapiens	Inhibition	%	2.19
	8094083	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-1.12	CHEMBL4574	Homo sapiens	Inhibition	%	-1.12
	8094263	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.76	CHEMBL4574	Homo sapiens	Inhibition	%	0.76
	8094487	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.62	CHEMBL4574	Homo sapiens	Inhibition	%	0.62
	8094662	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.22	CHEMBL4574	Homo sapiens	Inhibition	%	0.22
	8094818	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.49	CHEMBL4574	Homo sapiens	Inhibition	%	2.49
	8095042	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.32	CHEMBL4574	Homo sapiens	Inhibition	%	1.32
	8095182	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.96	CHEMBL4574	Homo sapiens	Inhibition	%	1.96
	8095385	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.33	CHEMBL4574	Homo sapiens	Inhibition	%	4.33
	8095609	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.61	CHEMBL4574	Homo sapiens	Inhibition	%	-0.61
	8095750	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.53	CHEMBL4574	Homo sapiens	Inhibition	%	6.53
	8095898	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.79	CHEMBL4574	Homo sapiens	Inhibition	%	0.79
	8096122	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.84	CHEMBL4574	Homo sapiens	Inhibition	%	4.84
	8096239	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.52	CHEMBL4574	Homo sapiens	Inhibition	%	2.52
	8096602	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.49	CHEMBL4574	Homo sapiens	Inhibition	%	1.49
	8096758	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.02	CHEMBL4574	Homo sapiens	Inhibition	%	4.02
	8096982	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.68	CHEMBL4574	Homo sapiens	Inhibition	%	4.68
	8097129	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.9	CHEMBL4574	Homo sapiens	Inhibition	%	1.9
	8097436	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.37	CHEMBL4574	Homo sapiens	Inhibition	%	3.37
	8097660	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.82	CHEMBL4574	Homo sapiens	Inhibition	%	4.82
	8097810	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.0	CHEMBL4574	Homo sapiens	Inhibition	%	5.0
	8098167	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	9.32	CHEMBL4574	Homo sapiens	Inhibition	%	9.32
	8098287	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.26	CHEMBL4574	Homo sapiens	Inhibition	%	0.26
	8098691	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.91	CHEMBL4574	Homo sapiens	Inhibition	%	0.91
	8098876	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.71	CHEMBL4574	Homo sapiens	Inhibition	%	1.71
	8099244	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.39	CHEMBL4574	Homo sapiens	Inhibition	%	3.39
	8099386	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.99	CHEMBL4574	Homo sapiens	Inhibition	%	3.99
	8099804	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.09	CHEMBL4574	Homo sapiens	Inhibition	%	1.09
	8099951	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.73	CHEMBL4574	Homo sapiens	Inhibition	%	5.73
	8100321	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	3.56	CHEMBL4574	Homo sapiens	Inhibition	%	3.56
	8100437	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.08	CHEMBL4574	Homo sapiens	Inhibition	%	3.08
	8100661	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.71	CHEMBL4574	Homo sapiens	Inhibition	%	0.71
	8100801	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.79	CHEMBL4574	Homo sapiens	Inhibition	%	2.79
	8101185	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.59	CHEMBL4574	Homo sapiens	Inhibition	%	8.59
	8101327	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.44	CHEMBL4574	Homo sapiens	Inhibition	%	0.44
	8101736	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	28.08	CHEMBL4574	Homo sapiens	Inhibition	%	28.08
	8101989	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	29.77	CHEMBL4574	Homo sapiens	Inhibition	%	29.77
	8102144	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.15	CHEMBL4574	Homo sapiens	Inhibition	%	2.15
	8102499	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.36	CHEMBL4574	Homo sapiens	Inhibition	%	3.36
	8102619	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	4.17	CHEMBL4574	Homo sapiens	Inhibition	%	4.17
	8102843	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.2	CHEMBL4574	Homo sapiens	Inhibition	%	1.2
	8103021	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.54	CHEMBL4574	Homo sapiens	Inhibition	%	1.54
	8103217	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-0.02	CHEMBL4574	Homo sapiens	Inhibition	%	-0.02
	8103579	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.1	CHEMBL4574	Homo sapiens	Inhibition	%	0.1
	8103729	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.95	CHEMBL4574	Homo sapiens	Inhibition	%	4.95
	8103953	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.29	CHEMBL4574	Homo sapiens	Inhibition	%	4.29
	8104138	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.18	CHEMBL4574	Homo sapiens	Inhibition	%	1.18
	8104286	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	12.68	CHEMBL4574	Homo sapiens	Inhibition	%	12.68
	8104510	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	38.55	CHEMBL4574	Homo sapiens	Inhibition	%	38.55
	8104656	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	23.81	CHEMBL4574	Homo sapiens	Inhibition	%	23.81
	8104994	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.75	CHEMBL4574	Homo sapiens	Inhibition	%	2.75
	8105134	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.2	CHEMBL4574	Homo sapiens	Inhibition	%	1.2
	8105524	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	37.91	CHEMBL4574	Homo sapiens	Inhibition	%	37.91
	8105662	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	10.52	CHEMBL4574	Homo sapiens	Inhibition	%	10.52
	8105886	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.68	CHEMBL4574	Homo sapiens	Inhibition	%	2.68
	8105942	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.34	CHEMBL4574	Homo sapiens	Inhibition	%	1.34
	8106166	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.36	CHEMBL4574	Homo sapiens	Inhibition	%	0.36
	8106331	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.82	CHEMBL4574	Homo sapiens	Inhibition	%	0.82
	8106487	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	19.32	CHEMBL4574	Homo sapiens	Inhibition	%	19.32
	8106711	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	7.19	CHEMBL4574	Homo sapiens	Inhibition	%	7.19
	8106840	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	6.08	CHEMBL4574	Homo sapiens	Inhibition	%	6.08
	8107185	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.5	CHEMBL4574	Homo sapiens	Inhibition	%	0.5
	8107357	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.43	CHEMBL4574	Homo sapiens	Inhibition	%	2.43
	8107558	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.58	CHEMBL4574	Homo sapiens	Inhibition	%	5.58
	8107782	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.19	CHEMBL4574	Homo sapiens	Inhibition	%	1.19
	8107917	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	8.9	CHEMBL4574	Homo sapiens	Inhibition	%	8.9
	8108299	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.88	CHEMBL4574	Homo sapiens	Inhibition	%	4.88
	8108474	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.86	CHEMBL4574	Homo sapiens	Inhibition	%	0.86
	8108845	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	72.75	CHEMBL4574	Homo sapiens	Inhibition	%	72.75
	8108987	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.25	CHEMBL4574	Homo sapiens	Inhibition	%	1.25
	8109325	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.04	CHEMBL4574	Homo sapiens	Inhibition	%	4.04
	8109455	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.96	CHEMBL4574	Homo sapiens	Inhibition	%	1.96
	8109679	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.46	CHEMBL4574	Homo sapiens	Inhibition	%	-0.46
	8109850	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	70.84	CHEMBL4574	Homo sapiens	Inhibition	%	70.84
	8110206	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.23	CHEMBL4574	Homo sapiens	Inhibition	%	7.23
	8110485	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.87	CHEMBL4574	Homo sapiens	Inhibition	%	1.87
	8110651	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.17	CHEMBL4574	Homo sapiens	Inhibition	%	4.17
	8111033	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	12.15	CHEMBL4574	Homo sapiens	Inhibition	%	12.15
	8111156	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.12	CHEMBL4574	Homo sapiens	Inhibition	%	3.12
	8111507	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.98	CHEMBL4574	Homo sapiens	Inhibition	%	0.98
	8111673	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	8.5	CHEMBL4574	Homo sapiens	Inhibition	%	8.5
	8111897	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	11.64	CHEMBL4574	Homo sapiens	Inhibition	%	11.64
	8112102	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.26	CHEMBL4574	Homo sapiens	Inhibition	%	4.26
	8112239	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.07	CHEMBL4574	Homo sapiens	Inhibition	%	-0.07
	8112463	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.93	CHEMBL4574	Homo sapiens	Inhibition	%	0.93
	8112631	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.28	CHEMBL4574	Homo sapiens	Inhibition	%	3.28
	8112803	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.28	CHEMBL4574	Homo sapiens	Inhibition	%	0.28
	8113179	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.24	CHEMBL4574	Homo sapiens	Inhibition	%	1.24
	8113315	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.98	CHEMBL4574	Homo sapiens	Inhibition	%	2.98
	8113539	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.27	CHEMBL4574	Homo sapiens	Inhibition	%	0.27
	8113663	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.92	CHEMBL4574	Homo sapiens	Inhibition	%	4.92
	8114003	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.55	CHEMBL4574	Homo sapiens	Inhibition	%	1.55
	8114179	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.95	CHEMBL4574	Homo sapiens	Inhibition	%	4.95
	8114535	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.09	CHEMBL4574	Homo sapiens	Inhibition	%	4.09
	8114811	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-1.13	CHEMBL4574	Homo sapiens	Inhibition	%	-1.13
	8114977	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.02	CHEMBL4574	Homo sapiens	Inhibition	%	2.02
	8115201	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.92	CHEMBL4574	Homo sapiens	Inhibition	%	6.92
	8115366	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.19	CHEMBL4574	Homo sapiens	Inhibition	%	1.19
	8115486	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	5.96	CHEMBL4574	Homo sapiens	Inhibition	%	5.96
	8115710	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.32	CHEMBL4574	Homo sapiens	Inhibition	%	2.32
	8115843	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.11	CHEMBL4574	Homo sapiens	Inhibition	%	1.11
	8116226	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	52.25	CHEMBL4574	Homo sapiens	Inhibition	%	52.25
	8116429	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.8	CHEMBL4574	Homo sapiens	Inhibition	%	2.8
	8116787	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.18	CHEMBL4574	Homo sapiens	Inhibition	%	-0.18
	8116959	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.56	CHEMBL4574	Homo sapiens	Inhibition	%	6.56
	8117130	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.27	CHEMBL4574	Homo sapiens	Inhibition	%	1.27
	8117354	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.33	CHEMBL4574	Homo sapiens	Inhibition	%	3.33
	8117512	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.81	CHEMBL4574	Homo sapiens	Inhibition	%	4.81
	8117866	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.32	CHEMBL4574	Homo sapiens	Inhibition	%	2.32
	8118004	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.75	CHEMBL4574	Homo sapiens	Inhibition	%	3.75
	8118344	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.02	CHEMBL4574	Homo sapiens	Inhibition	%	-0.02
	8118516	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	9.19	CHEMBL4574	Homo sapiens	Inhibition	%	9.19
	8118740	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.57	CHEMBL4574	Homo sapiens	Inhibition	%	1.57
	8118876	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.5	CHEMBL4574	Homo sapiens	Inhibition	%	7.5
	8119147	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.37	CHEMBL4574	Homo sapiens	Inhibition	%	0.37
	8119530	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	10.29	CHEMBL4574	Homo sapiens	Inhibition	%	10.29
	8119697	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	5.79	CHEMBL4574	Homo sapiens	Inhibition	%	5.79
	8120040	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	6.52	CHEMBL4574	Homo sapiens	Inhibition	%	6.52
	8120179	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.24	CHEMBL4574	Homo sapiens	Inhibition	%	0.24
	8120403	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.79	CHEMBL4574	Homo sapiens	Inhibition	%	0.79
	8120563	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.3	CHEMBL4574	Homo sapiens	Inhibition	%	1.3
	8120764	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	19.25	CHEMBL4574	Homo sapiens	Inhibition	%	19.25
	8121116	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	7.2	CHEMBL4574	Homo sapiens	Inhibition	%	7.2
	8121288	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.6	CHEMBL4574	Homo sapiens	Inhibition	%	1.6
	8121679	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	15.78	CHEMBL4574	Homo sapiens	Inhibition	%	15.78
	8121842	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.06	CHEMBL4574	Homo sapiens	Inhibition	%	3.06
	8122187	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.66	CHEMBL4574	Homo sapiens	Inhibition	%	-1.66
	8122325	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.29	CHEMBL4574	Homo sapiens	Inhibition	%	5.29
	8122549	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	32.99	CHEMBL4574	Homo sapiens	Inhibition	%	32.99
	8122669	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.59	CHEMBL4574	Homo sapiens	Inhibition	%	1.59
	8123060	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.54	CHEMBL4574	Homo sapiens	Inhibition	%	4.54
	8123202	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	14.77	CHEMBL4574	Homo sapiens	Inhibition	%	14.77
	8123480	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-2.24	CHEMBL4574	Homo sapiens	Inhibition	%	-2.24
	8123854	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	43.46	CHEMBL4574	Homo sapiens	Inhibition	%	43.46
	8124021	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.23	CHEMBL4574	Homo sapiens	Inhibition	%	-0.23
	8124364	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.75	CHEMBL4574	Homo sapiens	Inhibition	%	0.75
	8124727	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.7	CHEMBL4574	Homo sapiens	Inhibition	%	1.7
	8124892	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.58	CHEMBL4574	Homo sapiens	Inhibition	%	3.58
	8125093	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.84	CHEMBL4574	Homo sapiens	Inhibition	%	1.84
	8125317	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.86	CHEMBL4574	Homo sapiens	Inhibition	%	3.86
	8125447	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.35	CHEMBL4574	Homo sapiens	Inhibition	%	0.35
	8125615	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.92	CHEMBL4574	Homo sapiens	Inhibition	%	2.92
	8125839	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.14	CHEMBL4574	Homo sapiens	Inhibition	%	3.14
	8126003	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.7	CHEMBL4574	Homo sapiens	Inhibition	%	1.7
	8126167	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	17.05	CHEMBL4574	Homo sapiens	Inhibition	%	17.05
	8126391	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.2	CHEMBL4574	Homo sapiens	Inhibition	%	2.2
	8126506	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.75	CHEMBL4574	Homo sapiens	Inhibition	%	0.75
	8126866	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	62.41	CHEMBL4574	Homo sapiens	Inhibition	%	62.41
	8126988	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.27	CHEMBL4574	Homo sapiens	Inhibition	%	1.27
	8127212	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.66	CHEMBL4574	Homo sapiens	Inhibition	%	1.66
	8127379	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.63	CHEMBL4574	Homo sapiens	Inhibition	%	1.63
	8127521	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	52.38	CHEMBL4574	Homo sapiens	Inhibition	%	52.38
	8127745	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.5	CHEMBL4574	Homo sapiens	Inhibition	%	5.5
	8127809	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.74	CHEMBL4574	Homo sapiens	Inhibition	%	0.74
	8128033	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.26	CHEMBL4574	Homo sapiens	Inhibition	%	3.26
	8128185	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.48	CHEMBL4574	Homo sapiens	Inhibition	%	3.48
	8128352	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	6.3	CHEMBL4574	Homo sapiens	Inhibition	%	6.3
	8128576	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.31	CHEMBL4574	Homo sapiens	Inhibition	%	0.31
	8128695	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	10.36	CHEMBL4574	Homo sapiens	Inhibition	%	10.36
	8129056	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.68	CHEMBL4574	Homo sapiens	Inhibition	%	3.68
	8129227	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.42	CHEMBL4574	Homo sapiens	Inhibition	%	-0.42
	8129640	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.38	CHEMBL4574	Homo sapiens	Inhibition	%	0.38
	8129779	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.6	CHEMBL4574	Homo sapiens	Inhibition	%	1.6
	8130164	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	5.75	CHEMBL4574	Homo sapiens	Inhibition	%	5.75
	8130336	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.77	CHEMBL4574	Homo sapiens	Inhibition	%	3.77
	8130720	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	10.61	CHEMBL4574	Homo sapiens	Inhibition	%	10.61
	8130836	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.61	CHEMBL4574	Homo sapiens	Inhibition	%	0.61
	8131060	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.12	CHEMBL4574	Homo sapiens	Inhibition	%	1.12
	8131199	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.98	CHEMBL4574	Homo sapiens	Inhibition	%	4.98
	8131543	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.12	CHEMBL4574	Homo sapiens	Inhibition	%	0.12
	8131710	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	3.22	CHEMBL4574	Homo sapiens	Inhibition	%	3.22
	8132075	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.75	CHEMBL4574	Homo sapiens	Inhibition	%	9.75
	8132361	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.05	CHEMBL4574	Homo sapiens	Inhibition	%	0.05
	8132508	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.07	CHEMBL4574	Homo sapiens	Inhibition	%	6.07
	8132900	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	8.91	CHEMBL4574	Homo sapiens	Inhibition	%	8.91
	8133021	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.65	CHEMBL4574	Homo sapiens	Inhibition	%	1.65
	8133245	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.48	CHEMBL4574	Homo sapiens	Inhibition	%	4.48
	8133383	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.07	CHEMBL4574	Homo sapiens	Inhibition	%	2.07
	8133555	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.46	CHEMBL4574	Homo sapiens	Inhibition	%	1.46
	8133779	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.76	CHEMBL4574	Homo sapiens	Inhibition	%	1.76
	8133959	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	7.68	CHEMBL4574	Homo sapiens	Inhibition	%	7.68
	8134107	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.68	CHEMBL4574	Homo sapiens	Inhibition	%	0.68
	8134331	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.73	CHEMBL4574	Homo sapiens	Inhibition	%	1.73
	8134491	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.99	CHEMBL4574	Homo sapiens	Inhibition	%	1.99
	8134675	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	4.09	CHEMBL4574	Homo sapiens	Inhibition	%	4.09
	8134899	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	30.55	CHEMBL4574	Homo sapiens	Inhibition	%	30.55
	8135059	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.67	CHEMBL4574	Homo sapiens	Inhibition	%	1.67
	8135398	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.18	CHEMBL4574	Homo sapiens	Inhibition	%	3.18
	8135539	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	8.17	CHEMBL4574	Homo sapiens	Inhibition	%	8.17
	8135884	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.42	CHEMBL4574	Homo sapiens	Inhibition	%	1.42
	8136052	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.04	CHEMBL4574	Homo sapiens	Inhibition	%	1.04
	8136276	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.41	CHEMBL4574	Homo sapiens	Inhibition	%	2.41
	8136420	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.69	CHEMBL4574	Homo sapiens	Inhibition	%	3.69
	8136710	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.83	CHEMBL4574	Homo sapiens	Inhibition	%	0.83
	8136845	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.61	CHEMBL4574	Homo sapiens	Inhibition	%	1.61
	8137069	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	15.54	CHEMBL4574	Homo sapiens	Inhibition	%	15.54
	8137232	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	4.13	CHEMBL4574	Homo sapiens	Inhibition	%	4.13
	8137576	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.83	CHEMBL4574	Homo sapiens	Inhibition	%	0.83
	8137724	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.1	CHEMBL4574	Homo sapiens	Inhibition	%	-0.1
	8138114	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.8	CHEMBL4574	Homo sapiens	Inhibition	%	3.8
	8138293	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.24	CHEMBL4574	Homo sapiens	Inhibition	%	0.24
	8138665	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.51	CHEMBL4574	Homo sapiens	Inhibition	%	0.51
	8138823	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.95	CHEMBL4574	Homo sapiens	Inhibition	%	0.95
	8139232	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.3	CHEMBL4574	Homo sapiens	Inhibition	%	0.3
	8139391	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.37	CHEMBL4574	Homo sapiens	Inhibition	%	3.37
	8139729	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.31	CHEMBL4574	Homo sapiens	Inhibition	%	4.31
	8139870	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.06	CHEMBL4574	Homo sapiens	Inhibition	%	3.06
	8140094	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.57	CHEMBL4574	Homo sapiens	Inhibition	%	4.57
	8140217	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.07	CHEMBL4574	Homo sapiens	Inhibition	%	1.07
	8140600	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.91	CHEMBL4574	Homo sapiens	Inhibition	%	0.91
	8140743	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.73	CHEMBL4574	Homo sapiens	Inhibition	%	5.73
	8141045	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.98	CHEMBL4574	Homo sapiens	Inhibition	%	0.98
	8141399	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.55	CHEMBL4574	Homo sapiens	Inhibition	%	0.55
	8141559	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	29.03	CHEMBL4574	Homo sapiens	Inhibition	%	29.03
	8141902	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	5.16	CHEMBL4574	Homo sapiens	Inhibition	%	5.16
	8142063	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.33	CHEMBL4574	Homo sapiens	Inhibition	%	0.33
	8142287	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.64	CHEMBL4574	Homo sapiens	Inhibition	%	1.64
	8142455	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	33.9	CHEMBL4574	Homo sapiens	Inhibition	%	33.9
	8142631	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.3	CHEMBL4574	Homo sapiens	Inhibition	%	1.3
	8143004	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.61	CHEMBL4574	Homo sapiens	Inhibition	%	1.61
	8143159	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.82	CHEMBL4574	Homo sapiens	Inhibition	%	1.82
	8143383	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.94	CHEMBL4574	Homo sapiens	Inhibition	%	1.94
	8143570	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.23	CHEMBL4574	Homo sapiens	Inhibition	%	2.23
	8143729	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.33	CHEMBL4574	Homo sapiens	Inhibition	%	1.33
	8143953	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.25	CHEMBL4574	Homo sapiens	Inhibition	%	3.25
	8144067	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.54	CHEMBL4574	Homo sapiens	Inhibition	%	1.54
	8144430	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.03	CHEMBL4574	Homo sapiens	Inhibition	%	1.03
	8144560	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.38	CHEMBL4574	Homo sapiens	Inhibition	%	2.38
	8144937	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.02	CHEMBL4574	Homo sapiens	Inhibition	%	2.02
	8145074	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.29	CHEMBL4574	Homo sapiens	Inhibition	%	3.29
	8145298	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.94	CHEMBL4574	Homo sapiens	Inhibition	%	3.94
	8145387	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.3	CHEMBL4574	Homo sapiens	Inhibition	%	1.3
	8145735	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.63	CHEMBL4574	Homo sapiens	Inhibition	%	4.63
	8145896	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.74	CHEMBL4574	Homo sapiens	Inhibition	%	2.74
	8146120	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	8.66	CHEMBL4574	Homo sapiens	Inhibition	%	8.66
	8146240	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.46	CHEMBL4574	Homo sapiens	Inhibition	%	-0.46
	8146624	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.73	CHEMBL4574	Homo sapiens	Inhibition	%	0.73
	8146791	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	74.5	CHEMBL4574	Homo sapiens	Inhibition	%	74.5
	8146960	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.74	CHEMBL4574	Homo sapiens	Inhibition	%	3.74
	8147184	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	27.17	CHEMBL4574	Homo sapiens	Inhibition	%	27.17
	8147326	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.87	CHEMBL4574	Homo sapiens	Inhibition	%	1.87
	8147703	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.63	CHEMBL4574	Homo sapiens	Inhibition	%	2.63
	8147890	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	0.42	CHEMBL4574	Homo sapiens	Inhibition	%	0.42
	8148272	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.2	CHEMBL4574	Homo sapiens	Inhibition	%	0.2
	8148386	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.06	CHEMBL4574	Homo sapiens	Inhibition	%	2.06
	8148749	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.66	CHEMBL4574	Homo sapiens	Inhibition	%	4.66
	8148887	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.13	CHEMBL4574	Homo sapiens	Inhibition	%	1.13
	8149111	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.56	CHEMBL4574	Homo sapiens	Inhibition	%	1.56
	8149270	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.28	CHEMBL4574	Homo sapiens	Inhibition	%	0.28
	8149628	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.51	CHEMBL4574	Homo sapiens	Inhibition	%	2.51
	8149726	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.79	CHEMBL4574	Homo sapiens	Inhibition	%	1.79
	8149950	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	7.68	CHEMBL4574	Homo sapiens	Inhibition	%	7.68
	8150075	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.37	CHEMBL4574	Homo sapiens	Inhibition	%	-0.37
	8150459	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.59	CHEMBL4574	Homo sapiens	Inhibition	%	1.59
	8150579	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.01	CHEMBL4574	Homo sapiens	Inhibition	%	1.01
	8150803	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.2	CHEMBL4574	Homo sapiens	Inhibition	%	-0.2
	8150968	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.28	CHEMBL4574	Homo sapiens	Inhibition	%	-0.28
	8151131	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.54	CHEMBL4574	Homo sapiens	Inhibition	%	1.54
	8151532	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.62	CHEMBL4574	Homo sapiens	Inhibition	%	1.62
	8151670	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.68	CHEMBL4574	Homo sapiens	Inhibition	%	2.68
	8151894	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.01	CHEMBL4574	Homo sapiens	Inhibition	%	3.01
	8152048	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.85	CHEMBL4574	Homo sapiens	Inhibition	%	2.85
	8152236	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.14	CHEMBL4574	Homo sapiens	Inhibition	%	5.14
	8152618	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.56	CHEMBL4574	Homo sapiens	Inhibition	%	3.56
	8152732	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.82	CHEMBL4574	Homo sapiens	Inhibition	%	3.82
	8152956	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.12	CHEMBL4574	Homo sapiens	Inhibition	%	4.12
	8153095	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.16	CHEMBL4574	Homo sapiens	Inhibition	%	2.16
	8153456	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-0.27	CHEMBL4574	Homo sapiens	Inhibition	%	-0.27
	8153613	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.65	CHEMBL4574	Homo sapiens	Inhibition	%	0.65
	8153970	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	9.29	CHEMBL4574	Homo sapiens	Inhibition	%	9.29
	8154291	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.85	CHEMBL4574	Homo sapiens	Inhibition	%	1.85
	8154417	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.01	CHEMBL4574	Homo sapiens	Inhibition	%	1.01
	8154641	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.51	CHEMBL4574	Homo sapiens	Inhibition	%	-0.51
	8154800	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.03	CHEMBL4574	Homo sapiens	Inhibition	%	4.03
	8155144	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.44	CHEMBL4574	Homo sapiens	Inhibition	%	0.44
	8155320	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.15	CHEMBL4574	Homo sapiens	Inhibition	%	0.15
	8155481	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	5.84	CHEMBL4574	Homo sapiens	Inhibition	%	5.84
	8155705	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.84	CHEMBL4574	Homo sapiens	Inhibition	%	-0.84
	8155883	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.01	CHEMBL4574	Homo sapiens	Inhibition	%	4.01
	8156245	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.66	CHEMBL4574	Homo sapiens	Inhibition	%	2.66
	8156457	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.82	CHEMBL4574	Homo sapiens	Inhibition	%	2.82
	8156607	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.09	CHEMBL4574	Homo sapiens	Inhibition	%	4.09
	8156831	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.43	CHEMBL4574	Homo sapiens	Inhibition	%	2.43
	8156974	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	17.04	CHEMBL4574	Homo sapiens	Inhibition	%	17.04
	8157318	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	32.62	CHEMBL4574	Homo sapiens	Inhibition	%	32.62
	8157459	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.62	CHEMBL4574	Homo sapiens	Inhibition	%	5.62
	8157813	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.57	CHEMBL4574	Homo sapiens	Inhibition	%	3.57
	8157974	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.49	CHEMBL4574	Homo sapiens	Inhibition	%	2.49
	8158198	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.15	CHEMBL4574	Homo sapiens	Inhibition	%	1.15
	8158448	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	0.94	CHEMBL4574	Homo sapiens	Inhibition	%	0.94
	8158606	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.83	CHEMBL4574	Homo sapiens	Inhibition	%	4.83
	8158999	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	14.14	CHEMBL4574	Homo sapiens	Inhibition	%	14.14
	8159134	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.06	CHEMBL4574	Homo sapiens	Inhibition	%	2.06
	8159478	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.47	CHEMBL4574	Homo sapiens	Inhibition	%	0.47
	8159609	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.4	CHEMBL4574	Homo sapiens	Inhibition	%	7.4
	8159833	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.57	CHEMBL4574	Homo sapiens	Inhibition	%	2.57
	8159974	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.23	CHEMBL4574	Homo sapiens	Inhibition	%	4.23
	8160335	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.03	CHEMBL4574	Homo sapiens	Inhibition	%	3.03
	8160485	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.13	CHEMBL4574	Homo sapiens	Inhibition	%	1.13
	8160779	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.69	CHEMBL4574	Homo sapiens	Inhibition	%	4.69
	8161153	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.48	CHEMBL4574	Homo sapiens	Inhibition	%	5.48
	8161296	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	2.51	CHEMBL4574	Homo sapiens	Inhibition	%	2.51
	8161645	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.63	CHEMBL4574	Homo sapiens	Inhibition	%	1.63
	8161783	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	9.19	CHEMBL4574	Homo sapiens	Inhibition	%	9.19
	8162007	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.15	CHEMBL4574	Homo sapiens	Inhibition	%	3.15
	8162137	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	12.0	CHEMBL4574	Homo sapiens	Inhibition	%	12.0
	8162521	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.19	CHEMBL4574	Homo sapiens	Inhibition	%	0.19
	8162774	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.07	CHEMBL4574	Homo sapiens	Inhibition	%	6.07
	8162922	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	45.18	CHEMBL4574	Homo sapiens	Inhibition	%	45.18
	8163315	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.18	CHEMBL4574	Homo sapiens	Inhibition	%	1.18
	8163449	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.32	CHEMBL4574	Homo sapiens	Inhibition	%	3.32
	8163673	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.78	CHEMBL4574	Homo sapiens	Inhibition	%	1.78
	8163796	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.65	CHEMBL4574	Homo sapiens	Inhibition	%	3.65
	8164154	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.9	CHEMBL4574	Homo sapiens	Inhibition	%	2.9
	8164294	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.41	CHEMBL4574	Homo sapiens	Inhibition	%	1.41
	8164673	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.94	CHEMBL4574	Homo sapiens	Inhibition	%	2.94
	8164817	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.19	CHEMBL4574	Homo sapiens	Inhibition	%	1.19
	8165041	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.03	CHEMBL4574	Homo sapiens	Inhibition	%	2.03
	8165111	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.37	CHEMBL4574	Homo sapiens	Inhibition	%	3.37
	8165476	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.83	CHEMBL4574	Homo sapiens	Inhibition	%	0.83
	8165619	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	9.28	CHEMBL4574	Homo sapiens	Inhibition	%	9.28
	8165843	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.11	CHEMBL4574	Homo sapiens	Inhibition	%	1.11
	8165969	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	8.81	CHEMBL4574	Homo sapiens	Inhibition	%	8.81
	8166331	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	11.15	CHEMBL4574	Homo sapiens	Inhibition	%	11.15
	8166461	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.98	CHEMBL4574	Homo sapiens	Inhibition	%	1.98
	8166685	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.34	CHEMBL4574	Homo sapiens	Inhibition	%	4.34
	8166786	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.97	CHEMBL4574	Homo sapiens	Inhibition	%	1.97
	8167098	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.64	CHEMBL4574	Homo sapiens	Inhibition	%	1.64
	8167239	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	63.58	CHEMBL4574	Homo sapiens	Inhibition	%	63.58
	8167463	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.89	CHEMBL4574	Homo sapiens	Inhibition	%	4.89
	8167627	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.1	CHEMBL4574	Homo sapiens	Inhibition	%	6.1
	8167984	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.06	CHEMBL4574	Homo sapiens	Inhibition	%	5.06
	8168108	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.99	CHEMBL4574	Homo sapiens	Inhibition	%	1.99
	8168332	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	15.5	CHEMBL4574	Homo sapiens	Inhibition	%	15.5
	8168473	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.27	CHEMBL4574	Homo sapiens	Inhibition	%	2.27
	8168609	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.87	CHEMBL4574	Homo sapiens	Inhibition	%	5.87
	8168833	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	12.63	CHEMBL4574	Homo sapiens	Inhibition	%	12.63
	8168997	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	12.06	CHEMBL4574	Homo sapiens	Inhibition	%	12.06
	8169363	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.96	CHEMBL4574	Homo sapiens	Inhibition	%	4.96
	8169443	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	4.64	CHEMBL4574	Homo sapiens	Inhibition	%	4.64
	8169667	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	34.57	CHEMBL4574	Homo sapiens	Inhibition	%	34.57
	8169801	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.26	CHEMBL4574	Homo sapiens	Inhibition	%	4.26
	8170170	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.11	CHEMBL4574	Homo sapiens	Inhibition	%	0.11
	8170295	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.94	CHEMBL4574	Homo sapiens	Inhibition	%	0.94
	8170519	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.49	CHEMBL4574	Homo sapiens	Inhibition	%	4.49
	8170659	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.53	CHEMBL4574	Homo sapiens	Inhibition	%	2.53
	8171018	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.33	CHEMBL4574	Homo sapiens	Inhibition	%	1.33
	8171215	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.02	CHEMBL4574	Homo sapiens	Inhibition	%	2.02
	8171432	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.71	CHEMBL4574	Homo sapiens	Inhibition	%	2.71
	8171797	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.71	CHEMBL4574	Homo sapiens	Inhibition	%	4.71
	8171950	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.69	CHEMBL4574	Homo sapiens	Inhibition	%	2.69
	8172306	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.21	CHEMBL4574	Homo sapiens	Inhibition	%	5.21
	8172658	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.62	CHEMBL4574	Homo sapiens	Inhibition	%	0.62
	8172800	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.75	CHEMBL4574	Homo sapiens	Inhibition	%	3.75
	8173160	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	51.8	CHEMBL4574	Homo sapiens	Inhibition	%	51.8
	8173325	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	18.64	CHEMBL4574	Homo sapiens	Inhibition	%	18.64
	8173690	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.22	CHEMBL4574	Homo sapiens	Inhibition	%	2.22
	8174001	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	74.91	CHEMBL4574	Homo sapiens	Inhibition	%	74.91
	8174133	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.09	CHEMBL4574	Homo sapiens	Inhibition	%	1.09
	8174357	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.54	CHEMBL4574	Homo sapiens	Inhibition	%	6.54
	8174505	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.44	CHEMBL4574	Homo sapiens	Inhibition	%	1.44
	8174851	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.25	CHEMBL4574	Homo sapiens	Inhibition	%	2.25
	8174994	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	10.77	CHEMBL4574	Homo sapiens	Inhibition	%	10.77
	8175354	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.11	CHEMBL4574	Homo sapiens	Inhibition	%	4.11
	8175610	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	26.29	CHEMBL4574	Homo sapiens	Inhibition	%	26.29
	8175773	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.72	CHEMBL4574	Homo sapiens	Inhibition	%	0.72
	8175997	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	4.4	CHEMBL4574	Homo sapiens	Inhibition	%	4.4
	8176150	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.11	CHEMBL4574	Homo sapiens	Inhibition	%	4.11
	8176299	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	20.54	CHEMBL4574	Homo sapiens	Inhibition	%	20.54
	8176523	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	18.53	CHEMBL4574	Homo sapiens	Inhibition	%	18.53
	8176655	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	25.76	CHEMBL4574	Homo sapiens	Inhibition	%	25.76
	8177009	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.44	CHEMBL4574	Homo sapiens	Inhibition	%	4.44
	8177151	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.49	CHEMBL4574	Homo sapiens	Inhibition	%	2.49
	8177375	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	13.24	CHEMBL4574	Homo sapiens	Inhibition	%	13.24
	8177513	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	92.19	CHEMBL4574	Homo sapiens	Inhibition	%	92.19
	8177677	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	60.07	CHEMBL4574	Homo sapiens	Inhibition	%	60.07
	8177901	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.41	CHEMBL4574	Homo sapiens	Inhibition	%	2.41
	8178041	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.32	CHEMBL4574	Homo sapiens	Inhibition	%	2.32
	8178353	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.38	CHEMBL4574	Homo sapiens	Inhibition	%	2.38
	8178704	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.29	CHEMBL4574	Homo sapiens	Inhibition	%	5.29
	8178853	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.6	CHEMBL4574	Homo sapiens	Inhibition	%	-1.6
	8179200	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.26	CHEMBL4574	Homo sapiens	Inhibition	%	1.26
	8179344	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	17.25	CHEMBL4574	Homo sapiens	Inhibition	%	17.25
	8179568	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	55.76	CHEMBL4574	Homo sapiens	Inhibition	%	55.76
	8179705	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.68	CHEMBL4574	Homo sapiens	Inhibition	%	1.68
	8179962	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.62	CHEMBL4574	Homo sapiens	Inhibition	%	2.62
	8180340	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.79	CHEMBL4574	Homo sapiens	Inhibition	%	0.79
	8180496	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.49	CHEMBL4574	Homo sapiens	Inhibition	%	8.49
	8180868	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	54.24	CHEMBL4574	Homo sapiens	Inhibition	%	54.24
	8181001	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.1	CHEMBL4574	Homo sapiens	Inhibition	%	2.1
	8181225	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.1	CHEMBL4574	Homo sapiens	Inhibition	%	5.1
	8181356	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	4.55	CHEMBL4574	Homo sapiens	Inhibition	%	4.55
	8181720	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.64	CHEMBL4574	Homo sapiens	Inhibition	%	3.64
	8181859	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	94.93	CHEMBL4574	Homo sapiens	Inhibition	%	94.93
	8182246	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.28	CHEMBL4574	Homo sapiens	Inhibition	%	5.28
	8182386	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.46	CHEMBL4574	Homo sapiens	Inhibition	%	1.46
	8182610	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.71	CHEMBL4574	Homo sapiens	Inhibition	%	0.71
	8182702	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.85	CHEMBL4574	Homo sapiens	Inhibition	%	2.85
	8183048	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	17.75	CHEMBL4574	Homo sapiens	Inhibition	%	17.75
	8183197	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.33	CHEMBL4574	Homo sapiens	Inhibition	%	0.33
	8183421	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	0.66	CHEMBL4574	Homo sapiens	Inhibition	%	0.66
	8183550	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.76	CHEMBL4574	Homo sapiens	Inhibition	%	6.76
	8183916	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.16	CHEMBL4574	Homo sapiens	Inhibition	%	3.16
	8184052	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.08	CHEMBL4574	Homo sapiens	Inhibition	%	7.08
	8184318	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.52	CHEMBL4574	Homo sapiens	Inhibition	%	6.52
	8184689	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.01	CHEMBL4574	Homo sapiens	Inhibition	%	4.01
	8184846	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.21	CHEMBL4574	Homo sapiens	Inhibition	%	0.21
	8185070	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-0.44	CHEMBL4574	Homo sapiens	Inhibition	%	-0.44
	8185219	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.29	CHEMBL4574	Homo sapiens	Inhibition	%	1.29
	8185574	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.96	CHEMBL4574	Homo sapiens	Inhibition	%	3.96
	8185705	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	31.15	CHEMBL4574	Homo sapiens	Inhibition	%	31.15
	8186068	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	19.74	CHEMBL4574	Homo sapiens	Inhibition	%	19.74
	8186209	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.66	CHEMBL4574	Homo sapiens	Inhibition	%	5.66
	8186433	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.14	CHEMBL4574	Homo sapiens	Inhibition	%	7.14
	8186597	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.56	CHEMBL4574	Homo sapiens	Inhibition	%	2.56
	8186960	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.14	CHEMBL4574	Homo sapiens	Inhibition	%	2.14
	8187058	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.91	CHEMBL4574	Homo sapiens	Inhibition	%	2.91
	8187282	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	9.42	CHEMBL4574	Homo sapiens	Inhibition	%	9.42
	8187406	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.27	CHEMBL4574	Homo sapiens	Inhibition	%	2.27
	8187778	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.46	CHEMBL4574	Homo sapiens	Inhibition	%	0.46
	8187907	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	11.65	CHEMBL4574	Homo sapiens	Inhibition	%	11.65
	8188274	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	14.9	CHEMBL4574	Homo sapiens	Inhibition	%	14.9
	8188409	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	20.12	CHEMBL4574	Homo sapiens	Inhibition	%	20.12
	8188633	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	60.79	CHEMBL4574	Homo sapiens	Inhibition	%	60.79
	8188683	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.05	CHEMBL4574	Homo sapiens	Inhibition	%	1.05
	8188907	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.26	CHEMBL4574	Homo sapiens	Inhibition	%	4.26
	8189055	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.52	CHEMBL4574	Homo sapiens	Inhibition	%	1.52
	8189435	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.23	CHEMBL4574	Homo sapiens	Inhibition	%	5.23
	8189584	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	5.12	CHEMBL4574	Homo sapiens	Inhibition	%	5.12
	8189940	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	10.01	CHEMBL4574	Homo sapiens	Inhibition	%	10.01
	8190072	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.97	CHEMBL4574	Homo sapiens	Inhibition	%	5.97
	8190296	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.72	CHEMBL4574	Homo sapiens	Inhibition	%	4.72
	8190436	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.64	CHEMBL4574	Homo sapiens	Inhibition	%	1.64
	8190797	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.24	CHEMBL4574	Homo sapiens	Inhibition	%	2.24
	8190961	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.2	CHEMBL4574	Homo sapiens	Inhibition	%	3.2
	8191323	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.34	CHEMBL4574	Homo sapiens	Inhibition	%	4.34
	8191643	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.18	CHEMBL4574	Homo sapiens	Inhibition	%	0.18
	8191765	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.88	CHEMBL4574	Homo sapiens	Inhibition	%	3.88
	8192138	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.3	CHEMBL4574	Homo sapiens	Inhibition	%	0.3
	8192267	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.42	CHEMBL4574	Homo sapiens	Inhibition	%	3.42
	8192491	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	13.02	CHEMBL4574	Homo sapiens	Inhibition	%	13.02
	8192635	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.54	CHEMBL4574	Homo sapiens	Inhibition	%	3.54
	8192995	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.89	CHEMBL4574	Homo sapiens	Inhibition	%	1.89
	8193267	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.65	CHEMBL4574	Homo sapiens	Inhibition	%	1.65
	8193412	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	12.14	CHEMBL4574	Homo sapiens	Inhibition	%	12.14
	8193793	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	25.98	CHEMBL4574	Homo sapiens	Inhibition	%	25.98
	8193942	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.48	CHEMBL4574	Homo sapiens	Inhibition	%	1.48
	8194166	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.56	CHEMBL4574	Homo sapiens	Inhibition	%	3.56
	8194297	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.07	CHEMBL4574	Homo sapiens	Inhibition	%	3.07
	8194652	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.92	CHEMBL4574	Homo sapiens	Inhibition	%	2.92
	8194795	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.72	CHEMBL4574	Homo sapiens	Inhibition	%	2.72
	8195152	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.29	CHEMBL4574	Homo sapiens	Inhibition	%	6.29
	8195316	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.02	CHEMBL4574	Homo sapiens	Inhibition	%	3.02
	8195540	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	13.13	CHEMBL4574	Homo sapiens	Inhibition	%	13.13
	8195679	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.0	CHEMBL4574	Homo sapiens	Inhibition	%	2.0
	8196001	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	5.63	CHEMBL4574	Homo sapiens	Inhibition	%	5.63
	8196118	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.93	CHEMBL4574	Homo sapiens	Inhibition	%	1.93
	8196342	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.0	CHEMBL4574	Homo sapiens	Inhibition	%	5.0
	8196492	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.27	CHEMBL4574	Homo sapiens	Inhibition	%	1.27
	8196844	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	16.65	CHEMBL4574	Homo sapiens	Inhibition	%	16.65
	8196985	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	17.41	CHEMBL4574	Homo sapiens	Inhibition	%	17.41
	8197209	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.96	CHEMBL4574	Homo sapiens	Inhibition	%	0.96
	8197346	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	6.6	CHEMBL4574	Homo sapiens	Inhibition	%	6.6
	8197621	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.63	CHEMBL4574	Homo sapiens	Inhibition	%	2.63
	8197761	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	12.4	CHEMBL4574	Homo sapiens	Inhibition	%	12.4
	8197985	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	48.64	CHEMBL4574	Homo sapiens	Inhibition	%	48.64
	8198142	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.52	CHEMBL4574	Homo sapiens	Inhibition	%	0.52
	8198504	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.49	CHEMBL4574	Homo sapiens	Inhibition	%	1.49
	8198634	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.2	CHEMBL4574	Homo sapiens	Inhibition	%	6.2
	8198989	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.2	CHEMBL4574	Homo sapiens	Inhibition	%	3.2
	8199137	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.85	CHEMBL4574	Homo sapiens	Inhibition	%	3.85
	8199361	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.52	CHEMBL4574	Homo sapiens	Inhibition	%	4.52
	8199495	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	0.86	CHEMBL4574	Homo sapiens	Inhibition	%	0.86
	8199882	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.26	CHEMBL4574	Homo sapiens	Inhibition	%	2.26
	8200020	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.59	CHEMBL4574	Homo sapiens	Inhibition	%	0.59
	8200348	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.16	CHEMBL4574	Homo sapiens	Inhibition	%	-0.16
	8200687	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.62	CHEMBL4574	Homo sapiens	Inhibition	%	4.62
	8200837	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.62	CHEMBL4574	Homo sapiens	Inhibition	%	0.62
	8201191	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	60.65	CHEMBL4574	Homo sapiens	Inhibition	%	60.65
	8201550	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.69	CHEMBL4574	Homo sapiens	Inhibition	%	2.69
	8201683	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.33	CHEMBL4574	Homo sapiens	Inhibition	%	0.33
	8201962	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.37	CHEMBL4574	Homo sapiens	Inhibition	%	1.37
	8202326	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.58	CHEMBL4574	Homo sapiens	Inhibition	%	0.58
	8202493	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.5	CHEMBL4574	Homo sapiens	Inhibition	%	0.5
	8202842	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.96	CHEMBL4574	Homo sapiens	Inhibition	%	1.96
	8202972	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.92	CHEMBL4574	Homo sapiens	Inhibition	%	6.92
	8203196	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.49	CHEMBL4574	Homo sapiens	Inhibition	%	11.49
	8203327	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.95	CHEMBL4574	Homo sapiens	Inhibition	%	1.95
	8203697	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.69	CHEMBL4574	Homo sapiens	Inhibition	%	1.69
	8203831	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.6	CHEMBL4574	Homo sapiens	Inhibition	%	4.6
	8204055	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.08	CHEMBL4574	Homo sapiens	Inhibition	%	2.08
	8204221	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.54	CHEMBL4574	Homo sapiens	Inhibition	%	3.54
	8204358	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.25	CHEMBL4574	Homo sapiens	Inhibition	%	3.25
	8204582	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.89	CHEMBL4574	Homo sapiens	Inhibition	%	3.89
	8204687	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.21	CHEMBL4574	Homo sapiens	Inhibition	%	-0.21
	8205026	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	22.9	CHEMBL4574	Homo sapiens	Inhibition	%	22.9
	8205175	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.67	CHEMBL4574	Homo sapiens	Inhibition	%	3.67
	8205399	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.84	CHEMBL4574	Homo sapiens	Inhibition	%	7.84
	8205535	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.65	CHEMBL4574	Homo sapiens	Inhibition	%	7.65
	8205898	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.82	CHEMBL4574	Homo sapiens	Inhibition	%	1.82
	8206030	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	3.47	CHEMBL4574	Homo sapiens	Inhibition	%	3.47
	8206254	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.29	CHEMBL4574	Homo sapiens	Inhibition	%	2.29
	8206306	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.52	CHEMBL4574	Homo sapiens	Inhibition	%	3.52
	8206530	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.17	CHEMBL4574	Homo sapiens	Inhibition	%	1.17
	8206673	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	8.7	CHEMBL4574	Homo sapiens	Inhibition	%	8.7
	8206853	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.27	CHEMBL4574	Homo sapiens	Inhibition	%	0.27
	8207077	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.19	CHEMBL4574	Homo sapiens	Inhibition	%	1.19
	8207203	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.95	CHEMBL4574	Homo sapiens	Inhibition	%	1.95
	8207557	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	33.54	CHEMBL4574	Homo sapiens	Inhibition	%	33.54
	8207689	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.47	CHEMBL4574	Homo sapiens	Inhibition	%	2.47
	8207913	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.26	CHEMBL4574	Homo sapiens	Inhibition	%	2.26
	8208058	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.28	CHEMBL4574	Homo sapiens	Inhibition	%	1.28
	8208414	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.41	CHEMBL4574	Homo sapiens	Inhibition	%	3.41
	8208580	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.96	CHEMBL4574	Homo sapiens	Inhibition	%	3.96
	8208937	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.42	CHEMBL4574	Homo sapiens	Inhibition	%	8.42
	8209042	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	Inhibition	%	0.0
	8209266	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.51	CHEMBL4574	Homo sapiens	Inhibition	%	-0.51
	8209382	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.9	CHEMBL4574	Homo sapiens	Inhibition	%	0.9
	8209756	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.08	CHEMBL4574	Homo sapiens	Inhibition	%	4.08
	8209892	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	18.29	CHEMBL4574	Homo sapiens	Inhibition	%	18.29
	8210116	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	42.01	CHEMBL4574	Homo sapiens	Inhibition	%	42.01
	8210257	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.93	CHEMBL4574	Homo sapiens	Inhibition	%	3.93
	8210617	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	18.54	CHEMBL4574	Homo sapiens	Inhibition	%	18.54
	8210876	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.51	CHEMBL4574	Homo sapiens	Inhibition	%	2.51
	8211020	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.43	CHEMBL4574	Homo sapiens	Inhibition	%	2.43
	8211414	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.23	CHEMBL4574	Homo sapiens	Inhibition	%	1.23
	8211537	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.51	CHEMBL4574	Homo sapiens	Inhibition	%	4.51
	8211761	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.44	CHEMBL4574	Homo sapiens	Inhibition	%	2.44
	8211890	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	70.19	CHEMBL4574	Homo sapiens	Inhibition	%	70.19
	8212246	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.2	CHEMBL4574	Homo sapiens	Inhibition	%	3.2
	8212387	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.41	CHEMBL4574	Homo sapiens	Inhibition	%	6.41
	8212744	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.6	CHEMBL4574	Homo sapiens	Inhibition	%	6.6
	8212914	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	31.33	CHEMBL4574	Homo sapiens	Inhibition	%	31.33
	8213267	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	27.87	CHEMBL4574	Homo sapiens	Inhibition	%	27.87
	8213595	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.35	CHEMBL4574	Homo sapiens	Inhibition	%	0.35
	8213708	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.83	CHEMBL4574	Homo sapiens	Inhibition	%	3.83
	8213932	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.6	CHEMBL4574	Homo sapiens	Inhibition	%	0.6
	8214079	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.2	CHEMBL4574	Homo sapiens	Inhibition	%	7.2
	8214440	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	69.16	CHEMBL4574	Homo sapiens	Inhibition	%	69.16
	8214574	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.24	CHEMBL4574	Homo sapiens	Inhibition	%	2.24
	8214950	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	6.13	CHEMBL4574	Homo sapiens	Inhibition	%	6.13
	8215201	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.6	CHEMBL4574	Homo sapiens	Inhibition	%	0.6
	8215354	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.63	CHEMBL4574	Homo sapiens	Inhibition	%	4.63
	8215578	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.46	CHEMBL4574	Homo sapiens	Inhibition	%	2.46
	8215742	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.73	CHEMBL4574	Homo sapiens	Inhibition	%	0.73
	8216085	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.82	CHEMBL4574	Homo sapiens	Inhibition	%	2.82
	8216204	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.41	CHEMBL4574	Homo sapiens	Inhibition	%	2.41
	8216564	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.82	CHEMBL4574	Homo sapiens	Inhibition	%	5.82
	8216702	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	33.5	CHEMBL4574	Homo sapiens	Inhibition	%	33.5
	8216926	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.02	CHEMBL4574	Homo sapiens	Inhibition	%	4.02
	8217060	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.96	CHEMBL4574	Homo sapiens	Inhibition	%	3.96
	8217234	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	Inhibition	%	0.0
	8217458	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.39	CHEMBL4574	Homo sapiens	Inhibition	%	1.39
	8217589	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	53.66	CHEMBL4574	Homo sapiens	Inhibition	%	53.66
	8217914	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.78	CHEMBL4574	Homo sapiens	Inhibition	%	-1.78
	8218253	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.51	CHEMBL4574	Homo sapiens	Inhibition	%	3.51
	8218380	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	33.3	CHEMBL4574	Homo sapiens	Inhibition	%	33.3
	8218747	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	8.06	CHEMBL4574	Homo sapiens	Inhibition	%	8.06
	8218878	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	9.72	CHEMBL4574	Homo sapiens	Inhibition	%	9.72
	8219102	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.2	CHEMBL4574	Homo sapiens	Inhibition	%	1.2
	8219262	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.06	CHEMBL4574	Homo sapiens	Inhibition	%	4.06
	8219512	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.72	CHEMBL4574	Homo sapiens	Inhibition	%	1.72
	8219897	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.44	CHEMBL4574	Homo sapiens	Inhibition	%	4.44
	8220066	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.37	CHEMBL4574	Homo sapiens	Inhibition	%	3.37
	8220419	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.4	CHEMBL4574	Homo sapiens	Inhibition	%	1.4
	8220533	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.25	CHEMBL4574	Homo sapiens	Inhibition	%	4.25
	8220757	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.64	CHEMBL4574	Homo sapiens	Inhibition	%	1.64
	8220895	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	20.08	CHEMBL4574	Homo sapiens	Inhibition	%	20.08
	8221255	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	27.12	CHEMBL4574	Homo sapiens	Inhibition	%	27.12
	8221388	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.72	CHEMBL4574	Homo sapiens	Inhibition	%	1.72
	8221777	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.03	CHEMBL4574	Homo sapiens	Inhibition	%	0.03
	8221908	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	82.21	CHEMBL4574	Homo sapiens	Inhibition	%	82.21
	8222132	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.89	CHEMBL4574	Homo sapiens	Inhibition	%	4.89
	8222230	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.58	CHEMBL4574	Homo sapiens	Inhibition	%	1.58
	8222588	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.58	CHEMBL4574	Homo sapiens	Inhibition	%	2.58
	8222706	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	71.98	CHEMBL4574	Homo sapiens	Inhibition	%	71.98
	8222930	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.42	CHEMBL4574	Homo sapiens	Inhibition	%	6.42
	8223074	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	13.91	CHEMBL4574	Homo sapiens	Inhibition	%	13.91
	8223427	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.83	CHEMBL4574	Homo sapiens	Inhibition	%	2.83
	8223588	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.82	CHEMBL4574	Homo sapiens	Inhibition	%	2.82
	8223838	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.12	CHEMBL4574	Homo sapiens	Inhibition	%	1.12
	8224062	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.04	CHEMBL4574	Homo sapiens	Inhibition	%	3.04
	8224224	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.81	CHEMBL4574	Homo sapiens	Inhibition	%	2.81
	8224394	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.96	CHEMBL4574	Homo sapiens	Inhibition	%	0.96
	8224618	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.03	CHEMBL4574	Homo sapiens	Inhibition	%	3.03
	8224753	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.15	CHEMBL4574	Homo sapiens	Inhibition	%	2.15
	8225091	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	8.61	CHEMBL4574	Homo sapiens	Inhibition	%	8.61
	8225225	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.59	CHEMBL4574	Homo sapiens	Inhibition	%	3.59
	8225587	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.52	CHEMBL4574	Homo sapiens	Inhibition	%	1.52
	8225722	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.39	CHEMBL4574	Homo sapiens	Inhibition	%	3.39
	8225946	CHEMBL1961950	GSK_PKIS: BRSK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.72	CHEMBL4574	Homo sapiens	Inhibition	%	2.72
	8226104	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.24	CHEMBL4574	Homo sapiens	Inhibition	%	0.24
	8226453	CHEMBL1961951	GSK_PKIS: BRSK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.83	CHEMBL4574	Homo sapiens	Inhibition	%	10.83
	10838656	CHEMBL2014534	Inhibition of BRSK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	30.0	CHEMBL4574	Homo sapiens	INH	%	30.0
	10839538	CHEMBL2015927	Inhibition of BRSK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	11.0	CHEMBL4574	Homo sapiens	Activity	%	11.0
	10839629	CHEMBL2015835	Inhibition of BRSK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	28.0	CHEMBL4574	Homo sapiens	Activity	%	28.0
	12170838	CHEMBL2212705	Inhibition of BRSK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	91.0	CHEMBL4574	Homo sapiens	Activity	%	91.0
	12172139	CHEMBL2214394	Inhibition of BRSK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	12173719	CHEMBL2211633	Inhibition of BRSK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	87.0	CHEMBL4574	Homo sapiens	Activity	%	87.0
	12190846	CHEMBL2213801	Inhibition of BRSK2	B	Cn1cc(Nc2ncc(C3CC3)c(NCCCNC(=O)C3CCC3)n2)cn1		CHEMBL2207208	=	IC50	nM	3700.0	CHEMBL4574	Homo sapiens	IC50	uM	3.7
	12190847	CHEMBL2213801	Inhibition of BRSK2	B	O=C(NCCCNc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1C1CC1)C1CCC1		CHEMBL2207198	=	IC50	nM	1900.0	CHEMBL4574	Homo sapiens	IC50	uM	1.9
	12241335	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12241336	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	73.0	CHEMBL4574	Homo sapiens	Residual Activity	%	73.0
	12241337	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	83.0	CHEMBL4574	Homo sapiens	Residual Activity	%	83.0
	12241338	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	77.0	CHEMBL4574	Homo sapiens	Residual Activity	%	77.0
	12241339	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	84.0	CHEMBL4574	Homo sapiens	Residual Activity	%	84.0
	12241340	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12241341	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	36.0	CHEMBL4574	Homo sapiens	Residual Activity	%	36.0
	12241342	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	91.0	CHEMBL4574	Homo sapiens	Residual Activity	%	91.0
	12241343	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL4574	Homo sapiens	Residual Activity	%	102.0
	12241344	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	91.0	CHEMBL4574	Homo sapiens	Residual Activity	%	91.0
	12241345	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	94.0	CHEMBL4574	Homo sapiens	Residual Activity	%	94.0
	12241346	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12241347	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12241348	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	111.0	CHEMBL4574	Homo sapiens	Residual Activity	%	111.0
	12241349	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12241350	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12241351	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	111.0	CHEMBL4574	Homo sapiens	Residual Activity	%	111.0
	12241352	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	108.0	CHEMBL4574	Homo sapiens	Residual Activity	%	108.0
	12241353	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12241354	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	13.0	CHEMBL4574	Homo sapiens	Residual Activity	%	13.0
	12241355	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12241356	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12241357	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12241358	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12241359	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	119.0	CHEMBL4574	Homo sapiens	Residual Activity	%	119.0
	12241360	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	95.0	CHEMBL4574	Homo sapiens	Residual Activity	%	95.0
	12241361	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	37.0	CHEMBL4574	Homo sapiens	Residual Activity	%	37.0
	12241362	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	91.0	CHEMBL4574	Homo sapiens	Residual Activity	%	91.0
	12241363	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12241364	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12241365	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12241366	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12241367	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	108.0	CHEMBL4574	Homo sapiens	Residual Activity	%	108.0
	12241368	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	102.0	CHEMBL4574	Homo sapiens	Residual Activity	%	102.0
	12241369	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12241370	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	109.0	CHEMBL4574	Homo sapiens	Residual Activity	%	109.0
	12241371	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	104.0	CHEMBL4574	Homo sapiens	Residual Activity	%	104.0
	12241372	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12241373	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	114.0	CHEMBL4574	Homo sapiens	Residual Activity	%	114.0
	12241374	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12241375	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	131.0	CHEMBL4574	Homo sapiens	Residual Activity	%	131.0
	12241376	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL4574	Homo sapiens	Residual Activity	%	110.0
	12241377	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	7.0	CHEMBL4574	Homo sapiens	Residual Activity	%	7.0
	12241378	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL4574	Homo sapiens	Residual Activity	%	10.0
	12241379	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12241380	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12241381	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	127.0	CHEMBL4574	Homo sapiens	Residual Activity	%	127.0
	12241382	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	100.0	CHEMBL4574	Homo sapiens	Residual Activity	%	100.0
	12241383	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	121.0	CHEMBL4574	Homo sapiens	Residual Activity	%	121.0
	12241384	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12241385	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	67.0	CHEMBL4574	Homo sapiens	Residual Activity	%	67.0
	12241386	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	63.0	CHEMBL4574	Homo sapiens	Residual Activity	%	63.0
	12241387	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	11.0	CHEMBL4574	Homo sapiens	Residual Activity	%	11.0
	12241388	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12241389	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12241390	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	125.0	CHEMBL4574	Homo sapiens	Residual Activity	%	125.0
	12241391	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	124.0	CHEMBL4574	Homo sapiens	Residual Activity	%	124.0
	12241392	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12241393	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	114.0	CHEMBL4574	Homo sapiens	Residual Activity	%	114.0
	12241394	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12241395	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	86.0	CHEMBL4574	Homo sapiens	Residual Activity	%	86.0
	12241396	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	4.0	CHEMBL4574	Homo sapiens	Residual Activity	%	4.0
	12241397	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12241398	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12241399	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12241400	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	90.0	CHEMBL4574	Homo sapiens	Residual Activity	%	90.0
	12241401	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL4574	Homo sapiens	Residual Activity	%	92.0
	12241402	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	98.0	CHEMBL4574	Homo sapiens	Residual Activity	%	98.0
	12241403	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	78.0	CHEMBL4574	Homo sapiens	Residual Activity	%	78.0
	12241404	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12241405	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12241406	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	93.0	CHEMBL4574	Homo sapiens	Residual Activity	%	93.0
	12241407	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	71.0	CHEMBL4574	Homo sapiens	Residual Activity	%	71.0
	12244008	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12244009	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	94.0	CHEMBL4574	Homo sapiens	Residual Activity	%	94.0
	12244010	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	79.0	CHEMBL4574	Homo sapiens	Residual Activity	%	79.0
	12244011	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	76.0	CHEMBL4574	Homo sapiens	Residual Activity	%	76.0
	12244012	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	29.0	CHEMBL4574	Homo sapiens	Residual Activity	%	29.0
	12244013	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	80.0	CHEMBL4574	Homo sapiens	Residual Activity	%	80.0
	12244014	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL4574	Homo sapiens	Residual Activity	%	-1.0
	12244015	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL4574	Homo sapiens	Residual Activity	%	101.0
	12244016	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	40.0	CHEMBL4574	Homo sapiens	Residual Activity	%	40.0
	12244017	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	69.0	CHEMBL4574	Homo sapiens	Residual Activity	%	69.0
	12244018	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	123.0	CHEMBL4574	Homo sapiens	Residual Activity	%	123.0
	12244019	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	40.0	CHEMBL4574	Homo sapiens	Residual Activity	%	40.0
	12244020	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12244021	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	121.0	CHEMBL4574	Homo sapiens	Residual Activity	%	121.0
	12244022	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	102.0	CHEMBL4574	Homo sapiens	Residual Activity	%	102.0
	12244023	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12244024	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	10.0	CHEMBL4574	Homo sapiens	Residual Activity	%	10.0
	12244025	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12244026	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244027	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	59.0	CHEMBL4574	Homo sapiens	Residual Activity	%	59.0
	12244028	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12244029	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244030	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	117.0	CHEMBL4574	Homo sapiens	Residual Activity	%	117.0
	12244031	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	93.0	CHEMBL4574	Homo sapiens	Residual Activity	%	93.0
	12244032	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244033	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	110.0	CHEMBL4574	Homo sapiens	Residual Activity	%	110.0
	12244034	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12244035	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	23.0	CHEMBL4574	Homo sapiens	Residual Activity	%	23.0
	12244036	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL4574	Homo sapiens	Residual Activity	%	1.0
	12244037	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	123.0	CHEMBL4574	Homo sapiens	Residual Activity	%	123.0
	12244038	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	53.0	CHEMBL4574	Homo sapiens	Residual Activity	%	53.0
	12244039	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	32.0	CHEMBL4574	Homo sapiens	Residual Activity	%	32.0
	12244040	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	110.0	CHEMBL4574	Homo sapiens	Residual Activity	%	110.0
	12244041	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	114.0	CHEMBL4574	Homo sapiens	Residual Activity	%	114.0
	12244042	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12244043	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12244044	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	60.0	CHEMBL4574	Homo sapiens	Residual Activity	%	60.0
	12244045	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	118.0	CHEMBL4574	Homo sapiens	Residual Activity	%	118.0
	12244046	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12244047	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	39.0	CHEMBL4574	Homo sapiens	Residual Activity	%	39.0
	12244048	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12244049	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	116.0	CHEMBL4574	Homo sapiens	Residual Activity	%	116.0
	12244050	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	119.0	CHEMBL4574	Homo sapiens	Residual Activity	%	119.0
	12244051	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	83.0	CHEMBL4574	Homo sapiens	Residual Activity	%	83.0
	12244052	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	114.0	CHEMBL4574	Homo sapiens	Residual Activity	%	114.0
	12244053	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	128.0	CHEMBL4574	Homo sapiens	Residual Activity	%	128.0
	12244054	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	122.0	CHEMBL4574	Homo sapiens	Residual Activity	%	122.0
	12244055	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12244056	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	111.0	CHEMBL4574	Homo sapiens	Residual Activity	%	111.0
	12244057	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	118.0	CHEMBL4574	Homo sapiens	Residual Activity	%	118.0
	12244058	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244059	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	33.0	CHEMBL4574	Homo sapiens	Residual Activity	%	33.0
	12244060	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12244061	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	122.0	CHEMBL4574	Homo sapiens	Residual Activity	%	122.0
	12244062	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	125.0	CHEMBL4574	Homo sapiens	Residual Activity	%	125.0
	12244063	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	104.0	CHEMBL4574	Homo sapiens	Residual Activity	%	104.0
	12244064	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL4574	Homo sapiens	Residual Activity	%	0.0
	12244065	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	114.0	CHEMBL4574	Homo sapiens	Residual Activity	%	114.0
	12244066	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12244067	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	64.0	CHEMBL4574	Homo sapiens	Residual Activity	%	64.0
	12244068	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	118.0	CHEMBL4574	Homo sapiens	Residual Activity	%	118.0
	12244069	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	75.0	CHEMBL4574	Homo sapiens	Residual Activity	%	75.0
	12244070	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	122.0	CHEMBL4574	Homo sapiens	Residual Activity	%	122.0
	12244071	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	111.0	CHEMBL4574	Homo sapiens	Residual Activity	%	111.0
	12244072	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	88.0	CHEMBL4574	Homo sapiens	Residual Activity	%	88.0
	12244073	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	4.0	CHEMBL4574	Homo sapiens	Residual Activity	%	4.0
	12244074	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	101.0	CHEMBL4574	Homo sapiens	Residual Activity	%	101.0
	12244075	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244076	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL4574	Homo sapiens	Residual Activity	%	107.0
	12244077	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	104.0	CHEMBL4574	Homo sapiens	Residual Activity	%	104.0
	12244078	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244079	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	119.0	CHEMBL4574	Homo sapiens	Residual Activity	%	119.0
	12244080	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	116.0	CHEMBL4574	Homo sapiens	Residual Activity	%	116.0
	12244081	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	52.0	CHEMBL4574	Homo sapiens	Residual Activity	%	52.0
	12244082	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12244083	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	65.0	CHEMBL4574	Homo sapiens	Residual Activity	%	65.0
	12244084	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	111.0	CHEMBL4574	Homo sapiens	Residual Activity	%	111.0
	12244085	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	48.0	CHEMBL4574	Homo sapiens	Residual Activity	%	48.0
	12244086	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	91.0	CHEMBL4574	Homo sapiens	Residual Activity	%	91.0
	12244087	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	119.0	CHEMBL4574	Homo sapiens	Residual Activity	%	119.0
	12244088	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244089	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	117.0	CHEMBL4574	Homo sapiens	Residual Activity	%	117.0
	12244090	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244091	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	124.0	CHEMBL4574	Homo sapiens	Residual Activity	%	124.0
	12244092	CHEMBL2218966	Millipore: Percentage of residual kinase activity of BRSK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	100.0	CHEMBL4574	Homo sapiens	Residual Activity	%	100.0
	12244093	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	63.0	CHEMBL4574	Homo sapiens	Residual Activity	%	63.0
	12244094	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	35.0	CHEMBL4574	Homo sapiens	Residual Activity	%	35.0
	12244095	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	47.0	CHEMBL4574	Homo sapiens	Residual Activity	%	47.0
	12244096	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	100.0	CHEMBL4574	Homo sapiens	Residual Activity	%	100.0
	12244097	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	26.0	CHEMBL4574	Homo sapiens	Residual Activity	%	26.0
	12244098	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	54.0	CHEMBL4574	Homo sapiens	Residual Activity	%	54.0
	12244099	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	19.0	CHEMBL4574	Homo sapiens	Residual Activity	%	19.0
	12244100	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	51.0	CHEMBL4574	Homo sapiens	Residual Activity	%	51.0
	12244101	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244102	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	62.0	CHEMBL4574	Homo sapiens	Residual Activity	%	62.0
	12244103	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	100.0	CHEMBL4574	Homo sapiens	Residual Activity	%	100.0
	12244104	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	94.0	CHEMBL4574	Homo sapiens	Residual Activity	%	94.0
	12244105	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	63.0	CHEMBL4574	Homo sapiens	Residual Activity	%	63.0
	12244106	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	98.0	CHEMBL4574	Homo sapiens	Residual Activity	%	98.0
	12244107	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12244108	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL4574	Homo sapiens	Residual Activity	%	101.0
	12244109	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	129.0	CHEMBL4574	Homo sapiens	Residual Activity	%	129.0
	12244110	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	67.0	CHEMBL4574	Homo sapiens	Residual Activity	%	67.0
	12244111	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244112	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	4.0	CHEMBL4574	Homo sapiens	Residual Activity	%	4.0
	12244113	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12244114	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	92.0	CHEMBL4574	Homo sapiens	Residual Activity	%	92.0
	12244115	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	117.0	CHEMBL4574	Homo sapiens	Residual Activity	%	117.0
	12244116	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	109.0	CHEMBL4574	Homo sapiens	Residual Activity	%	109.0
	12244117	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	135.0	CHEMBL4574	Homo sapiens	Residual Activity	%	135.0
	12244118	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	60.0	CHEMBL4574	Homo sapiens	Residual Activity	%	60.0
	12244119	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	6.0	CHEMBL4574	Homo sapiens	Residual Activity	%	6.0
	12244120	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	34.0	CHEMBL4574	Homo sapiens	Residual Activity	%	34.0
	12244121	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	126.0	CHEMBL4574	Homo sapiens	Residual Activity	%	126.0
	12244122	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	52.0	CHEMBL4574	Homo sapiens	Residual Activity	%	52.0
	12244123	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12244124	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	94.0	CHEMBL4574	Homo sapiens	Residual Activity	%	94.0
	12244125	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	133.0	CHEMBL4574	Homo sapiens	Residual Activity	%	133.0
	12244126	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	108.0	CHEMBL4574	Homo sapiens	Residual Activity	%	108.0
	12244127	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	115.0	CHEMBL4574	Homo sapiens	Residual Activity	%	115.0
	12244128	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12244129	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	88.0	CHEMBL4574	Homo sapiens	Residual Activity	%	88.0
	12244130	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	139.0	CHEMBL4574	Homo sapiens	Residual Activity	%	139.0
	12244131	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	112.0	CHEMBL4574	Homo sapiens	Residual Activity	%	112.0
	12244132	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244133	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	126.0	CHEMBL4574	Homo sapiens	Residual Activity	%	126.0
	12244134	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	120.0	CHEMBL4574	Homo sapiens	Residual Activity	%	120.0
	12244135	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	6.0	CHEMBL4574	Homo sapiens	Residual Activity	%	6.0
	12244136	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL4574	Homo sapiens	Residual Activity	%	1.0
	12244137	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12244138	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	61.0	CHEMBL4574	Homo sapiens	Residual Activity	%	61.0
	12244139	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	127.0	CHEMBL4574	Homo sapiens	Residual Activity	%	127.0
	12244140	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	48.0	CHEMBL4574	Homo sapiens	Residual Activity	%	48.0
	12244141	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	118.0	CHEMBL4574	Homo sapiens	Residual Activity	%	118.0
	12244142	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	100.0	CHEMBL4574	Homo sapiens	Residual Activity	%	100.0
	12244143	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	31.0	CHEMBL4574	Homo sapiens	Residual Activity	%	31.0
	12244144	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	61.0	CHEMBL4574	Homo sapiens	Residual Activity	%	61.0
	12244145	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL4574	Homo sapiens	Residual Activity	%	1.0
	12244146	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	33.0	CHEMBL4574	Homo sapiens	Residual Activity	%	33.0
	12244147	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244148	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244149	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12244150	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	72.0	CHEMBL4574	Homo sapiens	Residual Activity	%	72.0
	12244151	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	73.0	CHEMBL4574	Homo sapiens	Residual Activity	%	73.0
	12244152	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244153	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	47.0	CHEMBL4574	Homo sapiens	Residual Activity	%	47.0
	12244154	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	3.0	CHEMBL4574	Homo sapiens	Residual Activity	%	3.0
	12244155	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244156	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244157	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	137.0	CHEMBL4574	Homo sapiens	Residual Activity	%	137.0
	12244158	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	61.0	CHEMBL4574	Homo sapiens	Residual Activity	%	61.0
	12244159	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12244160	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL4574	Homo sapiens	Residual Activity	%	95.0
	12244161	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	77.0	CHEMBL4574	Homo sapiens	Residual Activity	%	77.0
	12244162	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	102.0	CHEMBL4574	Homo sapiens	Residual Activity	%	102.0
	12244163	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12244164	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	40.0	CHEMBL4574	Homo sapiens	Residual Activity	%	40.0
	12244165	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	22.0	CHEMBL4574	Homo sapiens	Residual Activity	%	22.0
	12244166	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	116.0	CHEMBL4574	Homo sapiens	Residual Activity	%	116.0
	12244167	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	65.0	CHEMBL4574	Homo sapiens	Residual Activity	%	65.0
	12244168	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244169	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	62.0	CHEMBL4574	Homo sapiens	Residual Activity	%	62.0
	12244170	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	10.0	CHEMBL4574	Homo sapiens	Residual Activity	%	10.0
	12244171	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	67.0	CHEMBL4574	Homo sapiens	Residual Activity	%	67.0
	12244172	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL4574	Homo sapiens	Residual Activity	%	-2.0
	12244173	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	79.0	CHEMBL4574	Homo sapiens	Residual Activity	%	79.0
	12244174	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	15.0	CHEMBL4574	Homo sapiens	Residual Activity	%	15.0
	12244175	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	32.0	CHEMBL4574	Homo sapiens	Residual Activity	%	32.0
	12244176	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	82.0	CHEMBL4574	Homo sapiens	Residual Activity	%	82.0
	12244177	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	50.0	CHEMBL4574	Homo sapiens	Residual Activity	%	50.0
	12244178	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL4574	Homo sapiens	Residual Activity	%	105.0
	12244179	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	84.0	CHEMBL4574	Homo sapiens	Residual Activity	%	84.0
	12244180	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	90.0	CHEMBL4574	Homo sapiens	Residual Activity	%	90.0
	12244181	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12244182	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	5.0	CHEMBL4574	Homo sapiens	Residual Activity	%	5.0
	12244183	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12244184	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12244185	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	7.0	CHEMBL4574	Homo sapiens	Residual Activity	%	7.0
	12244186	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12244187	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	76.0	CHEMBL4574	Homo sapiens	Residual Activity	%	76.0
	12244188	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	80.0	CHEMBL4574	Homo sapiens	Residual Activity	%	80.0
	12244189	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	73.0	CHEMBL4574	Homo sapiens	Residual Activity	%	73.0
	12244190	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	77.0	CHEMBL4574	Homo sapiens	Residual Activity	%	77.0
	12244191	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12244192	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	83.0	CHEMBL4574	Homo sapiens	Residual Activity	%	83.0
	12244193	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	17.0	CHEMBL4574	Homo sapiens	Residual Activity	%	17.0
	12244194	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL4574	Homo sapiens	Residual Activity	%	0.0
	12244195	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	98.0	CHEMBL4574	Homo sapiens	Residual Activity	%	98.0
	12244196	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	52.0	CHEMBL4574	Homo sapiens	Residual Activity	%	52.0
	12244197	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	20.0	CHEMBL4574	Homo sapiens	Residual Activity	%	20.0
	12244198	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12244199	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL4574	Homo sapiens	Residual Activity	%	94.0
	12244200	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12244201	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	91.0	CHEMBL4574	Homo sapiens	Residual Activity	%	91.0
	12244202	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	29.0	CHEMBL4574	Homo sapiens	Residual Activity	%	29.0
	12244203	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244204	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12244205	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	13.0	CHEMBL4574	Homo sapiens	Residual Activity	%	13.0
	12244206	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	59.0	CHEMBL4574	Homo sapiens	Residual Activity	%	59.0
	12244207	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	88.0	CHEMBL4574	Homo sapiens	Residual Activity	%	88.0
	12244208	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL4574	Homo sapiens	Residual Activity	%	96.0
	12244209	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	18.0	CHEMBL4574	Homo sapiens	Residual Activity	%	18.0
	12244210	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	88.0	CHEMBL4574	Homo sapiens	Residual Activity	%	88.0
	12244211	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	82.0	CHEMBL4574	Homo sapiens	Residual Activity	%	82.0
	12244212	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	102.0	CHEMBL4574	Homo sapiens	Residual Activity	%	102.0
	12244213	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	45.0	CHEMBL4574	Homo sapiens	Residual Activity	%	45.0
	12244214	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	72.0	CHEMBL4574	Homo sapiens	Residual Activity	%	72.0
	12244215	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	104.0	CHEMBL4574	Homo sapiens	Residual Activity	%	104.0
	12244216	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12244217	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL4574	Homo sapiens	Residual Activity	%	4.0
	12244218	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	90.0	CHEMBL4574	Homo sapiens	Residual Activity	%	90.0
	12244219	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	106.0	CHEMBL4574	Homo sapiens	Residual Activity	%	106.0
	12244220	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	126.0	CHEMBL4574	Homo sapiens	Residual Activity	%	126.0
	12244221	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	95.0	CHEMBL4574	Homo sapiens	Residual Activity	%	95.0
	12244222	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL4574	Homo sapiens	Residual Activity	%	1.0
	12244223	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12244224	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	86.0	CHEMBL4574	Homo sapiens	Residual Activity	%	86.0
	12244225	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	9.0	CHEMBL4574	Homo sapiens	Residual Activity	%	9.0
	12244226	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL4574	Homo sapiens	Residual Activity	%	92.0
	12244227	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	20.0	CHEMBL4574	Homo sapiens	Residual Activity	%	20.0
	12244228	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	113.0	CHEMBL4574	Homo sapiens	Residual Activity	%	113.0
	12244229	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	68.0	CHEMBL4574	Homo sapiens	Residual Activity	%	68.0
	12244230	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	20.0	CHEMBL4574	Homo sapiens	Residual Activity	%	20.0
	12244231	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	6.0	CHEMBL4574	Homo sapiens	Residual Activity	%	6.0
	12244232	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	61.0	CHEMBL4574	Homo sapiens	Residual Activity	%	61.0
	12244233	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	103.0	CHEMBL4574	Homo sapiens	Residual Activity	%	103.0
	12244234	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	44.0	CHEMBL4574	Homo sapiens	Residual Activity	%	44.0
	12244235	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	41.0	CHEMBL4574	Homo sapiens	Residual Activity	%	41.0
	12244236	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	38.0	CHEMBL4574	Homo sapiens	Residual Activity	%	38.0
	12244237	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	97.0	CHEMBL4574	Homo sapiens	Residual Activity	%	97.0
	12244238	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	93.0	CHEMBL4574	Homo sapiens	Residual Activity	%	93.0
	12244239	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	21.0	CHEMBL4574	Homo sapiens	Residual Activity	%	21.0
	12244240	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	29.0	CHEMBL4574	Homo sapiens	Residual Activity	%	29.0
	12244241	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	12.0	CHEMBL4574	Homo sapiens	Residual Activity	%	12.0
	12244242	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	79.0	CHEMBL4574	Homo sapiens	Residual Activity	%	79.0
	12244243	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	7.0	CHEMBL4574	Homo sapiens	Residual Activity	%	7.0
	12244244	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	45.0	CHEMBL4574	Homo sapiens	Residual Activity	%	45.0
	12244245	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	89.0	CHEMBL4574	Homo sapiens	Residual Activity	%	89.0
	12244246	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	74.0	CHEMBL4574	Homo sapiens	Residual Activity	%	74.0
	12244247	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL4574	Homo sapiens	Residual Activity	%	90.0
	12246840	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	99.0	CHEMBL4574	Homo sapiens	Residual Activity	%	99.0
	12246841	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	90.0	CHEMBL4574	Homo sapiens	Residual Activity	%	90.0
	12246842	CHEMBL2218967	Millipore: Percentage of residual kinase activity of BRSK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	94.0	CHEMBL4574	Homo sapiens	Residual Activity	%	94.0
	12628462	CHEMBL2321413	Inhibition of BRSK2 (unknown origin) at 10 uM	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	12673089	CHEMBL2345630	Inhibition of recombinant BRSK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	67.0	CHEMBL4574	Homo sapiens	Activity	%	67.0
	12673090	CHEMBL2345630	Inhibition of recombinant BRSK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	77.0	CHEMBL4574	Homo sapiens	Activity	%	77.0
	12730923	CHEMBL2349851	Inhibition of BRSK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	93.0	CHEMBL4574	Homo sapiens	Activity	%	93.0
	13419688	CHEMBL2422262	Inhibition of BRSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	1.0	CHEMBL4574	Homo sapiens	INH	%	1.0
	13419689	CHEMBL2422262	Inhibition of BRSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	INH	%	0.0
	13419690	CHEMBL2422262	Inhibition of BRSK2 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	16.0	CHEMBL4574	Homo sapiens	INH	%	16.0
	13439890	CHEMBL2428180	Competitive binding affinity to BRSK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	13445400	CHEMBL2428180	Competitive binding affinity to BRSK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	69.0	CHEMBL4574	Homo sapiens	INH	%	69.0
	13448455	CHEMBL2428180	Competitive binding affinity to BRSK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	13451710	CHEMBL2428180	Competitive binding affinity to BRSK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	13476396	CHEMBL2438991	Inhibition of human wild type BRSK2 at 1 uM by qPCR analysis relative to control	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352	=	Inhibition	%	94.0	CHEMBL4574	Homo sapiens	INH	%	94.0
Active	13488395	CHEMBL2439412	Inhibition of human BRSK2 at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL4574	Homo sapiens	INH		
	13872199	CHEMBL3102386	Inhibition of human BrSK2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	108.0	CHEMBL4574	Homo sapiens	Activity	%	108.0
	13966037	CHEMBL3136652	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	28.0	CHEMBL4574	Homo sapiens	INH	%	28.0
	13973312	CHEMBL3135050	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	28.5	CHEMBL4574	Homo sapiens	INH	%	28.5
	13974030	CHEMBL3136622	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	INH	%	0.0
	13974121	CHEMBL3135767	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	36.0	CHEMBL4574	Homo sapiens	INH	%	36.0
	13974212	CHEMBL3135285	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	39.5	CHEMBL4574	Homo sapiens	INH	%	39.5
	13974950	CHEMBL3136855	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	60.5	CHEMBL4574	Homo sapiens	INH	%	60.5
	13975041	CHEMBL3136119	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	5.0	CHEMBL4574	Homo sapiens	INH	%	5.0
	13975132	CHEMBL3135843	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	INH	%	0.0
	13975223	CHEMBL3136381	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	2.5	CHEMBL4574	Homo sapiens	INH	%	2.5
	13975866	CHEMBL3135481	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	56.5	CHEMBL4574	Homo sapiens	INH	%	56.5
	13975959	CHEMBL3137013	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	13.0	CHEMBL4574	Homo sapiens	INH	%	13.0
	13976050	CHEMBL3135406	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	40.0	CHEMBL4574	Homo sapiens	INH	%	40.0
	13976141	CHEMBL3135078	Inhibition of human truncated BRSK2 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	43.0	CHEMBL4574	Homo sapiens	INH	%	43.0
	14582445	CHEMBL3240229	Inhibition of human BrSK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	14648112	CHEMBL3267013	Inhibition of human BRSK2 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	14648113	CHEMBL3267013	Inhibition of human BRSK2 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	15072441	CHEMBL3387478	Inhibition of BRSK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	102.0	CHEMBL4574	Homo sapiens	Activity	%	102.0
	15109386	CHEMBL3373396	Inhibition of BRSK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	32.0	CHEMBL4574	Homo sapiens	Activity	%	32.0
	15251884	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	31.0	CHEMBL4574	Homo sapiens	Activity	%	31.0
	15251913	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	27.0	CHEMBL4574	Homo sapiens	Activity	%	27.0
	15252015	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	86.0	CHEMBL4574	Homo sapiens	Activity	%	86.0
	15252660	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	73.0	CHEMBL4574	Homo sapiens	Activity	%	73.0
	15252762	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	60.0	CHEMBL4574	Homo sapiens	Activity	%	60.0
	15252864	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	66.0	CHEMBL4574	Homo sapiens	Activity	%	66.0
	15253538	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	74.0	CHEMBL4574	Homo sapiens	Activity	%	74.0
	15253640	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	69.0	CHEMBL4574	Homo sapiens	Activity	%	69.0
	15253742	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	68.0	CHEMBL4574	Homo sapiens	Activity	%	68.0
	15254408	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	46.0	CHEMBL4574	Homo sapiens	Activity	%	46.0
	15254510	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	63.0	CHEMBL4574	Homo sapiens	Activity	%	63.0
	15254612	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	41.0	CHEMBL4574	Homo sapiens	Activity	%	41.0
	15255303	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	50.0	CHEMBL4574	Homo sapiens	Activity	%	50.0
	15255405	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	63.0	CHEMBL4574	Homo sapiens	Activity	%	63.0
	15255508	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	34.0	CHEMBL4574	Homo sapiens	Activity	%	34.0
	15256239	CHEMBL3427818	Inhibition of BRSK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	36.0	CHEMBL4574	Homo sapiens	Activity	%	36.0
	15756096	CHEMBL3632170	Inhibition of BRSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	34.01	CHEMBL4574	Homo sapiens	INH	%	34.01
	15757076	CHEMBL3632170	Inhibition of BRSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	18.19	CHEMBL4574	Homo sapiens	INH	%	18.19
	15758003	CHEMBL3632170	Inhibition of BRSK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	26.43	CHEMBL4574	Homo sapiens	INH	%	26.43
	16431743	CHEMBL3748635	Inhibition of human BRSK2 using [KKLNRTLSFAEPG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4574	Homo sapiens	IC50	uM	10.0
	16495344	CHEMBL3776891	Inhibition of N-terminal His6-tagged recombinant human BRSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-4.0	CHEMBL4574	Homo sapiens	Activity	%	-4.0
	16508113	CHEMBL3776891	Inhibition of N-terminal His6-tagged recombinant human BRSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	12.0	CHEMBL4574	Homo sapiens	Activity	%	12.0
	16509090	CHEMBL3776891	Inhibition of N-terminal His6-tagged recombinant human BRSK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	5.0	CHEMBL4574	Homo sapiens	Activity	%	5.0
	16611831	CHEMBL3816643	Inhibition of human BRSK2 (2 to 674 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-65.0	CHEMBL4574	Homo sapiens	Activity	%	-65.0
	16611832	CHEMBL3816643	Inhibition of human BRSK2 (2 to 674 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-65.0	CHEMBL4574	Homo sapiens	Activity	%	-65.0
	16611833	CHEMBL3816643	Inhibition of human BRSK2 (2 to 674 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-12.0	CHEMBL4574	Homo sapiens	Activity	%	-12.0
	16611834	CHEMBL3816643	Inhibition of human BRSK2 (2 to 674 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-16.0	CHEMBL4574	Homo sapiens	Activity	%	-16.0
	16613781	CHEMBL3817217	Inhibition of human BRSK2 at 1 uM using [KKLNRTLSFAEPG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	4.0	CHEMBL4574	Homo sapiens	INH	%	4.0
	16654135	CHEMBL3829187	Inhibition of human BRSK2 (2 to 674residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	65.0	CHEMBL4574	Homo sapiens	Activity	%	65.0
	16837367	CHEMBL3876025	Inhibition of BRSK2 (unknown origin)	B	CC1(C)C(=O)N(C2CCCCC2)c2nc(Nc3ccccc3)ncc21		CHEMBL3883802	>	IC50	nM	10000.0	CHEMBL4574	Homo sapiens	IC50	nM	10000.0
	18114462	CHEMBL4025032	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	92.0	CHEMBL4574	Homo sapiens	Activity	%	92.0
	18203556	CHEMBL4043843	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	99.0	CHEMBL4574	Homo sapiens	Activity	%	99.0
	18232131	CHEMBL4050372	Inhibition of human BRSK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	91.0	CHEMBL4574	Homo sapiens	Activity	%	91.0
	18253743	CHEMBL4055156	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	18253744	CHEMBL4055156	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL4574	Homo sapiens	Activity	%	96.0
	18265816	CHEMBL4057266	Inhibition of BRSK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.3	CHEMBL4574	Homo sapiens	INH	%	13.3
	18266076	CHEMBL4057526	Inhibition of BRSK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-2.3	CHEMBL4574	Homo sapiens	INH	%	-2.3
	18282738	CHEMBL4120323	Inhibition of BRSK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	13.3	CHEMBL4574	Homo sapiens	INH	%	13.3
	18282915	CHEMBL4120500	Inhibition of BRSK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	6.3	CHEMBL4574	Homo sapiens	INH	%	6.3
	18283135	CHEMBL4120720	Inhibition of BRSK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-6.7	CHEMBL4574	Homo sapiens	INH	%	-6.7
	18440098	CHEMBL4156922	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	81.0	CHEMBL4574	Homo sapiens	Activity	%	81.0
	18449920	CHEMBL4178154	Inhibition of human BRSK2 (2 to 674 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	89.0	CHEMBL4574	Homo sapiens	Activity	%	89.0
	18484538	CHEMBL4185701	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	88.0	CHEMBL4574	Homo sapiens	Activity	%	88.0
	18485083	CHEMBL4185701	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	98.0	CHEMBL4574	Homo sapiens	Activity	%	98.0
	18507881	CHEMBL4190886	Inhibition of recombinant human BrSK2 (2 to end residues) at 1 uM using KKLNRTLSFAEPG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	3.0	CHEMBL4574	Homo sapiens	INH	%	3.0
	18653745	CHEMBL4230031	Inhibition of BRSK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-3.0	CHEMBL4574	Homo sapiens	INH	%	-3.0
	18653746	CHEMBL4230031	Inhibition of BRSK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	INH	%	0.0
	18654948	CHEMBL4230601	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	18674559	CHEMBL4235320	Inhibition of Brsk2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL4574	Homo sapiens	Ki	nM	10000.0
	18674560	CHEMBL4235320	Inhibition of Brsk2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL4574	Homo sapiens	Ki	nM	2000.0
Not Determined	18674561	CHEMBL4235320	Inhibition of Brsk2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL4574	Homo sapiens	Ki		
	18751060	CHEMBL4263745	Inhibition of BRSK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	13.0	CHEMBL4574	Homo sapiens	INH	%	13.0
	18751713	CHEMBL4264190	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	18764539	CHEMBL4267082	Inhibition of human BRSK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL4574	Homo sapiens	INH	%	70.0
	18764540	CHEMBL4267082	Inhibition of human BRSK2 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL4574	Homo sapiens	INH	%	70.0
	18764541	CHEMBL4267082	Inhibition of human BRSK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL4574	Homo sapiens	INH	%	70.0
	18857861	CHEMBL4307707	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	86.0	CHEMBL4574	Homo sapiens	Activity	%	86.0
	18937737	CHEMBL4327598	Inhibition of human BRSK2 assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.41	CHEMBL4574	Homo sapiens	Activity	%	100.41
	18937738	CHEMBL4327598	Inhibition of human BRSK2 assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.76	CHEMBL4574	Homo sapiens	Activity	%	95.76
	18938439	CHEMBL4327959	Inhibition of human BRSK2 assessed as residual activity at 100 uM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4574	Homo sapiens	Activity	%	65.0
	18938812	CHEMBL4328323	Inhibition of human BRSK2 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.33	CHEMBL4574	Homo sapiens	IC50	10'-9M	2.33
	18953710	CHEMBL4331907	Inhibition of BRSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	46.0	CHEMBL4574	Homo sapiens	INH	%	46.0
	18953776	CHEMBL4331907	Inhibition of BRSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	68.0	CHEMBL4574	Homo sapiens	INH	%	68.0
	18953821	CHEMBL4331907	Inhibition of BRSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	67.0	CHEMBL4574	Homo sapiens	INH	%	67.0
	18953913	CHEMBL4331966	Inhibition of BRSK2 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	19.0	CHEMBL4574	Homo sapiens	INH	%	19.0
	18953977	CHEMBL4331966	Inhibition of BRSK2 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL4574	Homo sapiens	INH	%	0.0
	18954044	CHEMBL4331907	Inhibition of BRSK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	35.0	CHEMBL4574	Homo sapiens	INH	%	35.0
	18958780	CHEMBL4333299	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	58.0	CHEMBL4574	Homo sapiens	Activity	%	58.0
Active	19041024	CHEMBL4352285	Inhibition of human BRSK2 at 10 uM using KKLNRTLSFAEPG as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4574	Homo sapiens	INH		
	19059478	CHEMBL4357779	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	19090051	CHEMBL4365625	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	97.0	CHEMBL4574	Homo sapiens	Activity	%	97.0
	19091827	CHEMBL4366301	Inhibition of human BRSK2 at 100 nM using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-1.64	CHEMBL4574	Homo sapiens	INH	%	-1.64
	19147755	CHEMBL4379151	Inhibition of recombinant human BRSK2 (2 to end residues) using KKLNRTLSFAEPG substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4574	Homo sapiens	IC50	uM	10.0
	19159306	CHEMBL4382410	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	49.0	CHEMBL4574	Homo sapiens	Activity	%	49.0
	19191701	CHEMBL4389129	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	92.0	CHEMBL4574	Homo sapiens	INH	%	92.0
	19191792	CHEMBL4389606	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	98.0	CHEMBL4574	Homo sapiens	INH	%	98.0
	19199990	CHEMBL4391232	Binding affinity to wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	70.0	CHEMBL4574	Homo sapiens	Activity	%	70.0
	19266324	CHEMBL4405274	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4574	Homo sapiens	INH	%	50.0
	19275942	CHEMBL4407945	Inhibition of recombinant human BRSK2 (2 to end residues) at 1 uM using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	54.0	CHEMBL4574	Homo sapiens	INH	%	54.0
	22423803	CHEMBL4674477	Inhibition of human BRSK2 using KKLNRTLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	106.31	CHEMBL4574	Homo sapiens	Activity	%	106.31
	22423804	CHEMBL4674477	Inhibition of human BRSK2 using KKLNRTLSFAEPG as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	61.22	CHEMBL4574	Homo sapiens	Activity	%	61.22
	22843486	CHEMBL4720483	Inhibition of human BRSK2 assessed as residual activity using KKLNRTLSFAEPG as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	111.51	CHEMBL4574	Homo sapiens	Activity	%	111.51
	22843835	CHEMBL4720821	Inhibition of human BRSK2 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.29	CHEMBL4574	Homo sapiens	IC50	10^-9M	3.29
	22844632	CHEMBL4721307	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	88.82	CHEMBL4574	Homo sapiens	Activity	%	88.82
	22952765	CHEMBL4766702	Inhibition of recombinant human BRSK2 (2 to end residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	96.0	CHEMBL4574	Homo sapiens	Activity	%	96.0
	23122464	CHEMBL4804815	Inhibition of human BRSK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	96.0	CHEMBL4574	Homo sapiens	Activity	%	96.0
	23123159	CHEMBL4805403	Inhibition of human BRSK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	23123728	CHEMBL4805972	Inhibition of DNA-tagged human BRSK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	23124408	CHEMBL4806420	Inhibition of human BRSK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	23124409	CHEMBL4806420	Inhibition of human BRSK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4574	Homo sapiens	Activity	%	100.0
	23127849	CHEMBL4807758	Inhibition of BRSK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	23127850	CHEMBL4807758	Inhibition of BRSK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	23127851	CHEMBL4807758	Inhibition of BRSK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4574	Homo sapiens	Activity	%	75.0
	23234021	CHEMBL4827600	Inhibition of wild-type human full length BRSK2 (M1 to L674 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccccc23)cc1C1CCCC1		CHEMBL4851925	<	Activity	%	10.0	CHEMBL4574	Homo sapiens	Activity	%	10.0
Not Active	23317299	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23317767	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Slightly Active	23318853	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	48.0	CHEMBL4574	Homo sapiens	% Control	%	48.0
Not Active	23318854	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794	>	Kd	nM	10000.0	CHEMBL4574	Homo sapiens	Kd	nM	10000.0
Not Active	23318917	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23319557	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	95.6	CHEMBL4574	Homo sapiens	% Control	%	95.6
Not Active	23320029	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	98.3	CHEMBL4574	Homo sapiens	% Control	%	98.3
Not Active	23320707	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23321175	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23321805	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL4574	Homo sapiens	% Control	%	97.0
Not Active	23322273	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23322962	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23323430	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	88.0	CHEMBL4574	Homo sapiens	% Control	%	88.0
Not Active	23323958	CHEMBL4880577	BrSK2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	21.0	CHEMBL4574	Homo sapiens	% inhibition	%	21.0
Not Active	23324284	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23324919	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23325387	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23326034	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL4574	Homo sapiens	% Control	%	91.0
Not Active	23326502	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	87.0	CHEMBL4574	Homo sapiens	% Control	%	87.0
Not Active	23327202	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23327670	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23328257	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23328725	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23329260	CHEMBL4880967	BrSK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	102.0	CHEMBL4574	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23329671	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23330139	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23330895	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23331363	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23331950	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	97.5	CHEMBL4574	Homo sapiens	% Control	%	97.5
Not Active	23332418	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23333134	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23333773	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23334241	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23335220	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	92.0	CHEMBL4574	Homo sapiens	% Control	%	92.0
Not Active	23335688	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23336315	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	96.0	CHEMBL4574	Homo sapiens	% Control	%	96.0
Not Active	23336783	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	86.0	CHEMBL4574	Homo sapiens	% Control	%	86.0
Not Active	23337864	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23338332	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	77.0	CHEMBL4574	Homo sapiens	% Control	%	77.0
Not Active	23338944	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23339412	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	72.0	CHEMBL4574	Homo sapiens	% Control	%	72.0
Not Active	23340049	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	84.0	CHEMBL4574	Homo sapiens	% Control	%	84.0
Not Active	23340517	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	77.0	CHEMBL4574	Homo sapiens	% Control	%	77.0
Not Active	23341174	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23341642	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23342258	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	97.0	CHEMBL4574	Homo sapiens	% Control	%	97.0
Not Active	23342726	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	76.0	CHEMBL4574	Homo sapiens	% Control	%	76.0
Not Active	23343356	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	67.0	CHEMBL4574	Homo sapiens	% Control	%	67.0
Not Active	23343824	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23344462	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23345035	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23345503	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23346080	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23346549	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	60.7	CHEMBL4574	Homo sapiens	% Control	%	60.7
Not Active	23347159	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	89.3	CHEMBL4574	Homo sapiens	% Control	%	89.3
Not Active	23347640	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	88.0	CHEMBL4574	Homo sapiens	% Control	%	88.0
Not Active	23348219	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23348687	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	90.0	CHEMBL4574	Homo sapiens	% Control	%	90.0
Not Active	23349274	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23349892	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23350360	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	97.0	CHEMBL4574	Homo sapiens	% Control	%	97.0
Not Active	23350965	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23351433	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23352457	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23352925	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23353807	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23354275	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23355007	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	93.0	CHEMBL4574	Homo sapiens	% Control	%	93.0
Not Active	23355475	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	94.0	CHEMBL4574	Homo sapiens	% Control	%	94.0
Not Active	23356111	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23356579	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	90.0	CHEMBL4574	Homo sapiens	% Control	%	90.0
Not Active	23357188	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23357835	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	90.0	CHEMBL4574	Homo sapiens	% Control	%	90.0
Not Active	23358303	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23358889	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	77.3	CHEMBL4574	Homo sapiens	% Control	%	77.3
Not Active	23359487	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	85.0	CHEMBL4574	Homo sapiens	% Control	%	85.0
Not Active	23359955	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	95.0	CHEMBL4574	Homo sapiens	% Control	%	95.0
Not Active	23360540	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	73.0	CHEMBL4574	Homo sapiens	% Control	%	73.0
Not Active	23361008	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	80.0	CHEMBL4574	Homo sapiens	% Control	%	80.0
Not Active	23361581	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	90.0	CHEMBL4574	Homo sapiens	% Control	%	90.0
Not Active	23362117	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	77.0	CHEMBL4574	Homo sapiens	% Control	%	77.0
Not Active	23362585	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	72.0	CHEMBL4574	Homo sapiens	% Control	%	72.0
Not Active	23364227	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	78.0	CHEMBL4574	Homo sapiens	% Control	%	78.0
Not Active	23364695	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	87.0	CHEMBL4574	Homo sapiens	% Control	%	87.0
Not Active	23365434	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	93.0	CHEMBL4574	Homo sapiens	% Control	%	93.0
Not Active	23365977	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23366567	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	79.0	CHEMBL4574	Homo sapiens	% Control	%	79.0
Not Active	23367035	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23367913	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	89.0	CHEMBL4574	Homo sapiens	% Control	%	89.0
Not Active	23368381	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL4574	Homo sapiens	% Control	%	95.0
Not Active	23368980	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23369448	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23369988	CHEMBL4884232	BrSK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	34.0	CHEMBL4574	Homo sapiens	% residual kinase activity	%	34.0
Slightly Active	23370416	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	36.0	CHEMBL4574	Homo sapiens	% Control	%	36.0
Not Active	23370884	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	92.0	CHEMBL4574	Homo sapiens	% Control	%	92.0
Not Active	23371693	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23372161	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	79.0	CHEMBL4574	Homo sapiens	% Control	%	79.0
Not Active	23375588	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23376056	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23376634	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23377103	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23377961	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	70.0	CHEMBL4574	Homo sapiens	% Control	%	70.0
Not Active	23378429	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	90.0	CHEMBL4574	Homo sapiens	% Control	%	90.0
Not Active	23379596	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23380064	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	77.0	CHEMBL4574	Homo sapiens	% Control	%	77.0
Not Active	23380758	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23381406	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23381874	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23382498	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4574	Homo sapiens	% Control	%	100.0
Not Active	23382966	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	97.0	CHEMBL4574	Homo sapiens	% Control	%	97.0
Not Active	23383583	CHEMBL4887243	BRSK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	102.0	CHEMBL4574	Homo sapiens	% Ctrl	%	102.0
Not Active	23384196	CHEMBL4887791	BrSK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	3.83	CHEMBL4574	Homo sapiens	% inhibition	%	3.83
Not Active	23384881	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	79.0	CHEMBL4574	Homo sapiens	% Control	%	79.0
Not Active	23385348	CHEMBL4879605	KinomeScan assay: inhibition of BRSK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	90.0	CHEMBL4574	Homo sapiens	% Control	%	90.0
